Executive summary: Diagnosis and Treatment of Catheter-Related Bloodstream Infection: Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC) | Enfermedades Infecciosas y Microbiología Clínica

array:24 ["pii" => "S0213005X17303130" "issn" => "0213005X" "doi" => "10.1016/j.eimc.2017.10.019" "estado" => "S300" "fechaPublicacion" => "2018-02-01" "aid" => "1771" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica" "copyrightAnyo" => "2017" "documento" => "article" "crossmark" => 1 "subdocumento" => "pgl" "cita" => "Enferm Infecc Microbiol Clin. 2018;36:112-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2710 "formatos" => array:2 [ "HTML" => 1945 "PDF" => 765 ] ] "Traduccion" => array:1 [ "en" => array:19 [ "pii" => "S2529993X18300431" "issn" => "2529993X" "doi" => "10.1016/j.eimce.2017.10.013" "estado" => "S300" "fechaPublicacion" => "2018-02-01" "aid" => "1771" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica" "documento" => "article" "crossmark" => 1 "subdocumento" => "pgl" "cita" => "Enferm Infecc Microbiol Clin. 2018;36:112-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 468 "formatos" => array:2 [ "HTML" => 311 "PDF" => 157 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "Consensus statement" "titulo" => "Executive summary: Diagnosis and Treatment of Catheter-Related Bloodstream Infection: Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC)" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "112" "paginaFinal" => "119" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Resumen ejecutivo del documento de consenso sobre diagnóstico y tratamiento de la bacteriemia relacionada con catèc)ter: Guía de Práctica Clínica de la Sociedad Española de Enfermedades Infecciosas (SEIMC) y de la Sociedad Española de Medicina Intensiva Crítica y Unidades Coronarias (SEMICYUC)" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Fernando Chaves, Josèc) Garnacho-Montero, Josèc) Luis del Pozo, Emilio Bouza, Josèc) Antonio Capdevila, Marina de Cueto, M. Ángeles Domínguez, Jaime Esteban, Nuria Fernández-Hidalgo, Marta Fernández Sampedro, Jesús Fortún, María Guembe, Leonardo Lorente, Jose Ramón Paño, Paula Ramírez, Miguel Salavert, Miguel Sánchez, Jordi Vallèc)s" "autores" => array:18 [ 0 => array:2 [ "nombre" => "Fernando" "apellidos" => "Chaves" ] 1 => array:2 [ "nombre" => "Josèc)" "apellidos" => "Garnacho-Montero" ] 2 => array:2 [ "nombre" => "Josèc) Luis" "apellidos" => "del Pozo" ] 3 => array:3 [ "preGrado" => "Authors:" "nombre" => "Emilio" "apellidos" => "Bouza" ] 4 => array:2 [ "nombre" => "Josèc) Antonio" "apellidos" => "Capdevila" ] 5 => array:2 [ "nombre" => "Marina" "apellidos" => "de Cueto" ] 6 => array:2 [ "nombre" => "M. Ángeles" "apellidos" => "Domínguez" ] 7 => array:2 [ "nombre" => "Jaime" "apellidos" => "Esteban" ] 8 => array:2 [ "nombre" => "Nuria" "apellidos" => "Fernández-Hidalgo" ] 9 => array:2 [ "nombre" => "Marta" "apellidos" => "Fernández Sampedro" ] 10 => array:2 [ "nombre" => "Jesús" "apellidos" => "Fortún" ] 11 => array:2 [ "nombre" => "María" "apellidos" => "Guembe" ] 12 => array:2 [ "nombre" => "Leonardo" "apellidos" => "Lorente" ] 13 => array:2 [ "nombre" => "Jose Ramón" "apellidos" => "Paño" ] 14 => array:2 [ "nombre" => "Paula" "apellidos" => "Ramírez" ] 15 => array:2 [ "nombre" => "Miguel" "apellidos" => "Salavert" ] 16 => array:2 [ "nombre" => "Miguel" "apellidos" => "Sánchez" ] 17 => array:2 [ "nombre" => "Jordi" "apellidos" => "Vallèc)s" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0213005X17303130" "doi" => "10.1016/j.eimc.2017.10.019" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X17303130?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X18300431?idApp=UINPBA00004N" "url" => "/2529993X/0000003600000002/v2_201802191141/S2529993X18300431/v2_201802191141/en/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S0213005X15004577" "issn" => "0213005X" "doi" => "10.1016/j.eimc.2015.11.019" "estado" => "S300" "fechaPublicacion" => "2018-02-01" "aid" => "1461" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica" "documento" => "article" "crossmark" => 1 "subdocumento" => "ssu" "cita" => "Enferm Infecc Microbiol Clin. 2018;36:120-36" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2623 "formatos" => array:3 [ "EPUB" => 2 "HTML" => 2103 "PDF" => 518 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "Revisión" "titulo" => "Helmintosis y eosinofilia en España (1990-2015)" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "120" "paginaFinal" => "136" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Helminthosis and eosinophilia in Spain (1990-2015)" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figura 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1632 "Ancho" => 2333 "Tamanyo" => 225596 ] ] "descripcion" => array:1 [ "es" => "Provincias con casos publicados de anisakidosis (1990-2015)." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Cristina Carranza-Rodríguez, Miriam Escamilla-González, Isabel Fuentes-Corripio, María-Jesús Perteguer-Prieto, Teresa Gárate-Ormaechea, José-Luis Pérez-Arellano" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Cristina" "apellidos" => "Carranza-Rodríguez" ] 1 => array:2 [ "nombre" => "Miriam" "apellidos" => "Escamilla-González" ] 2 => array:2 [ "nombre" => "Isabel" "apellidos" => "Fuentes-Corripio" ] 3 => array:2 [ "nombre" => "María-Jesús" "apellidos" => "Perteguer-Prieto" ] 4 => array:2 [ "nombre" => "Teresa" "apellidos" => "Gárate-Ormaechea" ] 5 => array:2 [ "nombre" => "José-Luis" "apellidos" => "Pérez-Arellano" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2529993X18300066" "doi" => "10.1016/j.eimce.2015.11.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X18300066?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X15004577?idApp=UINPBA00004N" "url" => "/0213005X/0000003600000002/v2_201802071725/S0213005X15004577/v2_201802071725/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0213005X17303695" "issn" => "0213005X" "doi" => "10.1016/j.eimc.2017.11.009" "estado" => "S300" "fechaPublicacion" => "2018-02-01" "aid" => "1787" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Enferm Infecc Microbiol Clin. 2018;36:104-11" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 5325 "formatos" => array:3 [ "EPUB" => 2 "HTML" => 4017 "PDF" => 1306 ] ] "es" => array:12 [ "idiomaDefecto" => true "cabecera" => "Formación médica continuada: infecciones por micobacterias" "titulo" => "Diagnóstico microbiológico de las infecciones causadas por el género Mycobacterium" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "104" "paginaFinal" => "111" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Microbiological diagnosis of infections caused by the genus Mycobacterium" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sofía Samper, Julià González-Martin" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Sofía" "apellidos" => "Samper" ] 1 => array:2 [ "nombre" => "Julià" "apellidos" => "González-Martin" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2529993X18300194" "doi" => "10.1016/j.eimce.2017.11.018" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X18300194?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X17303695?idApp=UINPBA00004N" "url" => "/0213005X/0000003600000002/v2_201802071725/S0213005X17303695/v2_201802071725/es/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "Consensus statement" "titulo" => "Executive summary: Diagnosis and Treatment of Catheter-Related Bloodstream Infection: Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC)" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "112" "paginaFinal" => "119" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Fernando Chaves, José Garnacho-Montero, José Luis del Pozo, Emilio Bouza, José Antonio Capdevila, Marina de Cueto, M. Ángeles Domínguez, Jaime Esteban, Nuria Fernández-Hidalgo, Marta Fernández Sampedro, Jesús Fortún, María Guembe, Leonardo Lorente, Jose Ramón Paño, Paula Ramírez, Miguel Salavert, Miguel Sánchez, Jordi Vallés" "autores" => array:18 [ 0 => array:3 [ "nombre" => "Fernando" "apellidos" => "Chaves" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff1" ] ] ] 1 => array:3 [ "nombre" => "José" "apellidos" => "Garnacho-Montero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0005" ] ] ] 2 => array:4 [ "nombre" => "José Luis" "apellidos" => "del Pozo" "email" => array:1 [ 0 => "jdelpozo@unav.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 3 => array:4 [ "preGrado" => "Authors:" "nombre" => "Emilio" "apellidos" => "Bouza" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "d" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "José Antonio" "apellidos" => "Capdevila" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "e" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "Marina" "apellidos" => "de Cueto" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "f" "identificador" => "aff0030" ] ] ] 6 => array:3 [ "nombre" => "M. Ángeles" "apellidos" => "Domínguez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "g" "identificador" => "aff0035" ] ] ] 7 => array:3 [ "nombre" => "Jaime" "apellidos" => "Esteban" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "h" "identificador" => "aff0040" ] ] ] 8 => array:3 [ "nombre" => "Nuria" "apellidos" => "Fernández-Hidalgo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "i" "identificador" => "aff0045" ] ] ] 9 => array:3 [ "nombre" => "Marta" "apellidos" => "Fernández Sampedro" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "j" "identificador" => "aff0050" ] ] ] 10 => array:3 [ "nombre" => "Jesús" "apellidos" => "Fortún" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "k" "identificador" => "aff0055" ] ] ] 11 => array:3 [ "nombre" => "María" "apellidos" => "Guembe" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "l" "identificador" => "aff0060" ] ] ] 12 => array:3 [ "nombre" => "Leonardo" "apellidos" => "Lorente" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "m" "identificador" => "aff0065" ] ] ] 13 => array:3 [ "nombre" => "Jose Ramón" "apellidos" => "Paño" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "n" "identificador" => "aff0070" ] ] ] 14 => array:3 [ "nombre" => "Paula" "apellidos" => "Ramírez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "o" "identificador" => "aff0075" ] ] ] 15 => array:3 [ "nombre" => "Miguel" "apellidos" => "Salavert" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "p" "identificador" => "aff0080" ] ] ] 16 => array:3 [ "nombre" => "Miguel" "apellidos" => "Sánchez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "q" "identificador" => "aff0085" ] ] ] 17 => array:3 [ "nombre" => "Jordi" "apellidos" => "Vallés" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "r" "identificador" => "aff0090" ] ] ] ] "afiliaciones" => array:18 [ 0 => array:3 [ "entidad" => "Servicio de Microbiología, Hospital Universitario 12 de Octubre, Madrid, España" "etiqueta" => "a" "identificador" => "aff1" ] 1 => array:3 [ "entidad" => "Unidad Clínica de Cuidados Intensivos, Hospital Universitario Virgen Macarena, Sevilla, España" "etiqueta" => "b" "identificador" => "aff0005" ] 2 => array:3 [ "entidad" => "Área de Enfermedades Infecciosas, Servicio de Microbiología, Clínica Universidad de Navarra, Pamplona, España" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid; CIBER de Enfermedades Respiratorias, CibeRes, Instituto de Salud Carlos III, Madrid; Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Servicio de Medicina Interna, Hospital de Mataró, Mataró, Barcelona, España" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Sevilla, España" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Microbiología, Hospital Universitari de Bellvitge, IDIBELL, L’Hospitalet de Llobregat, Barcelona, España" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Departamento de Microbiología Clínica, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, España" "etiqueta" => "h" "identificador" => "aff0040" ] 8 => array:3 [ "entidad" => "Servei de Malalties Infeccioses, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, España" "etiqueta" => "i" "identificador" => "aff0045" ] 9 => array:3 [ "entidad" => "Servicio de Enfermedades Infecciosas, Hospital Universitario Marqués de Valdecilla, Santander, España" "etiqueta" => "j" "identificador" => "aff0050" ] 10 => array:3 [ "entidad" => "Unidad de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, Madrid, España" "etiqueta" => "k" "identificador" => "aff0055" ] 11 => array:3 [ "entidad" => "Unidad de Enfermedades Infecciosas y Microbiología Clínica, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, España" "etiqueta" => "l" "identificador" => "aff0060" ] 12 => array:3 [ "entidad" => "Unidad de Cuidados Intensivos, Hospital Universitario de Canarias, Santa Cruz de Tenerife, España" "etiqueta" => "m" "identificador" => "aff0065" ] 13 => array:3 [ "entidad" => "Unidad de Enfermedades Infecciosas, Hospital Clínico Universitario Lozano Blesa, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, España" "etiqueta" => "n" "identificador" => "aff0070" ] 14 => array:3 [ "entidad" => "Unidad de Cuidados Intensivos, Hospital Universitari i Politècnic La Fe, Valencia; CIBER de Enfermedades Respiratorias (CibeRes), Instituto de Salud Carlos III, Madrid, España" "etiqueta" => "o" "identificador" => "aff0075" ] 15 => array:3 [ "entidad" => "Unidad de Enfermedades Infecciosas, Hospital Universitari i Politècnic La Fe, Valencia, España" "etiqueta" => "p" "identificador" => "aff0080" ] 16 => array:3 [ "entidad" => "Servicio de Medicina Intensiva, Hospital Clínico San Carlos, Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España" "etiqueta" => "q" "identificador" => "aff0085" ] 17 => array:3 [ "entidad" => "Unidad de Cuidados Intensivos, Hospital Universitari Parc Taulí, Sabadell, Barcelona; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, España" "etiqueta" => "r" "identificador" => "aff0090" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Resumen ejecutivo del documento de consenso sobre diagnóstico y tratamiento de la bacteriemia relacionada con catéter: Guía de Práctica Clínica de la Sociedad Española de Enfermedades Infecciosas (SEIMC) y de la Sociedad Española de Medicina Intensiva Crítica y Unidades Coronarias (SEMICYUC)" ] ] "textoCompleto" => "Introduction: justification and aimsIntravascular devices have become an essential component of modern medicine for the administration of intravenous fluids, medication, blood products and parenteral nutrition and for monitoring hemodynamic status and providing hemodialysis. According to national data supplied by the study of the prevalence of nosocomial infections in Spain (EPINE), it is estimated that about 70% of patients admitted to Spanish hospitals will wear one of these devices at some point during their stay.<a class="elsevierStyleCrossRef" href="#bib0040">1</a> Local or systemic infections represent one of the main associated complications.<a class="elsevierStyleCrossRef" href="#bib0045">2</a> The incidence of catheter-related infections varies considerably depending on the type and intended use, the insertion site, the experience and training of the individual who places the catheter, the frequency with which the catheter is accessed, duration of catheter placement, the characteristics of the patient, and the use of proven prevention strategies. Catheter-related bloodstream infections (CRBSIs) are among the most frequent infections acquired in hospital. Current estimates are that between 15 and 30% of all nosocomial bacteremias are catheter-related.<a class="elsevierStyleCrossRef" href="#bib0050">3</a> CRBSIs have significant associated morbidity, incur increased hospital costs,<a class="elsevierStyleCrossRef" href="#bib0055">4</a> estimated at approximately 18,000 euros per episode, and length of stay.<a class="elsevierStyleCrossRef" href="#bib0060">5</a> Attributable mortality ranges between 12 and 25%.<a class="elsevierStyleCrossRef" href="#bib0065">6</a> In recent years, there has been a remarkable increase in our knowledge of the epidemiology of CRBSI and of the most appropriate methodologies for diagnosis, management and prevention. The vast amount of information accumulated and the inherent complexity of this type of infection make it necessary to sort and analyze the available information. At the same time, there are few current guidelines available on this topic. The last Spanish catheter-related infections guidelines were published in 2004.<a class="elsevierStyleCrossRef" href="#bib0070">7</a> The aim of this new guide is to update recommendations for the diagnosis and management of catheter-related bloodstream infections. This document targets only microbiological diagnosis and antimicrobial therapy; other aspects of infection management and prevention are therefore excluded. Only adult patients with these infections are covered.MethodsThe two participating Societies (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica and the Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias) nominated three coordinators for this project (FC, JGM and JLdP: a microbiologist, an intensivist, and an infectious disease physician). This coordinating group selected the rest of the members of the panel, including microbiologists, intensivists, and infectious disease physicians. The Scientific Committees of both Societies approved their proposal. The present Statement was written following the SEIMC guidelines for consensus statements (<a href="http://www.seimc.org/">www.seimc.org</a>) as well as the recommendations of the AGREE Collaboration (<a href="http://www.agreecollaboration.org/">www.agreecollaboration.org</a>) for evaluating the methodological quality of clinical practice guidelines. The strength of the recommendations and quality of the evidence were graded in accordance with ESCMID guidelines (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).<elsevierMultimedia ident="tbl0005"></elsevierMultimedia>The coordinating group identified 39 key topics that were formulated in accordance with the PICO format defining the population, intervention, comparator, and outcome of interest. These key questions were approved by the Scientific Committees of both Societies and then distributed to the different members of the panel (2 or 3 questions each) for further development. The coordinating group wrote the first draft based on the sections submitted by each participant, which was then sent to the panel for critical review. Before its final approval, the document was published on the intranet of both Societies and left open to suggestions and comments from members. All authors and coordinators of the Statement have agreed the contents of the document and the final recommendations.General aspectsWhen should catheter-related bloodstream infection be suspected?Recommendations:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005">•CRBSI should be suspected in patients with intravenous catheters and fever, chills or other signs of sepsis, even in the absence of local signs of infection, and especially if no alternative source is identified (A-III).</li><li class="elsevierStyleListItem" id="lsti0010">•Clinical suspicion of CRBSI should also increase in patients with intravenous catheters who have metastatic infections caused by hematogenous spread of microorganisms (i.e. septic emboli) (A-III).</li><li class="elsevierStyleListItem" id="lsti0015">•Persistent or recurrent bacteremia caused by microorganisms that tend to colonize or infect the skin in patients with intravenous catheters should lead to suspicion of CRBSI (A-III).</li></ul>How is a complicated catheter-related bloodstream infection defined?Recommendations:<ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0020">•Patients with CRBSI with endocarditis, suppurative thrombophlebitis, septic metastasis, extraluminal infections, septic shock, non-resolving CRBSI, and immunocompromised patients should be categorized as complicated CRBSI (A-III).</li></ul>Diagnosis without catheter withdrawal (conservative diagnosis)How should blood cultures be taken?Recommendation:<ul class="elsevierStyleList" id="lis0015"><li class="elsevierStyleListItem" id="lsti0025">•Obtain blood cultures using an aseptic technique before the initiation of antimicrobial therapy (A-I)</li><li class="elsevierStyleListItem" id="lsti0030">•Skin preparation for obtaining blood samples drawn percutaneously should be performed with proper techniques, including the time to perform the procedure and leaving adequate time for the disinfectant to take effect (A-I). Alcohol-containing products are associated with low rates of contamination. Alcohol-chlorhexidine solutions reduce blood culture contamination more efficiently than aqueous povidone-iodine (A-I).</li><li class="elsevierStyleListItem" id="lsti0035">•In patients with suspected CRBSI, two pairs of blood cultures should be drawn, one from a peripheral vein and the other from the catheter (A-I).</li><li class="elsevierStyleListItem" id="lsti0040">•For multiple-lumen venous catheters, samples for blood culture should be obtained from all lumens (A-II).</li></ul>How should conventional blood cultures be interpreted?Recommendation:<ul class="elsevierStyleList" id="lis0020"><li class="elsevierStyleListItem" id="lsti0045">•For diagnosis of CRBSI, positivity of blood cultures obtained through the catheter ≥120min before those from a peripheral vein with the same microorganism is highly suggestive. An optimal DTP cut-off for the diagnosis of catheter-related candidemia has not been established. (A-II).</li><li class="elsevierStyleListItem" id="lsti0050">•The interpretation of DTP should consider adherence to the procedural technique used and the type of microorganism (A-II).</li><li class="elsevierStyleListItem" id="lsti0055">•Rapid microbial identification by MALDI-TOF MS from a positive blood culture significantly reduces time to identification of microorganisms and has clinical impact on the management of patients with suspected bloodstream infection (A-II).</li></ul>How should quantitative blood cultures be taken and interpreted?Recommendation:<ul class="elsevierStyleList" id="lis0025"><li class="elsevierStyleListItem" id="lsti0060">•A quantitative blood culture with a colony count 3 times greater in a sample drawn through a catheter than from the peripheral vein supports a diagnosis of CRBSI (A-II). This method is less practicable for routine use.</li></ul>What particular aspects should be considered for the diagnosis of CRBSI in patients on hemodialysis?Recommendations:<ul class="elsevierStyleList" id="lis0030"><li class="elsevierStyleListItem" id="lsti0065">•Whenever possible, paired blood samples from the CVC and a peripheral vein should be obtained for a CRBSI diagnosis in hemodialysis patients (A-II).</li><li class="elsevierStyleListItem" id="lsti0070">•Peripheral blood samples should be obtained from veins that are not intended for future creation of dialysis fistulae or grafts. The veins of the hand for outpatients and hand or femoral veins for hospital inpatients should be used to obtain peripheral blood cultures (A-III).</li><li class="elsevierStyleListItem" id="lsti0075">•If a blood sample cannot be drawn from a peripheral vein, two separate samples should be drawn, 10–15min apart, through the CVC or the dialysis circuit connected to the catheter (B-II).</li></ul>What is the present value of molecular techniques for the diagnosis of CRBSI?Recommendations:<ul class="elsevierStyleList" id="lis0035"><li class="elsevierStyleListItem" id="lsti0080">•At the present time, there is not enough information to recommend implementing these techniques in clinical practice for CRBSI diagnosis (C-II).</li></ul>Diagnosis of CRBI with catheter withdrawalWhen should a catheter tip be sent for culture?Recommendations:<ul class="elsevierStyleList" id="lis0040"><li class="elsevierStyleListItem" id="lsti0085">•Catheter cultures should only be obtained when catheter-related bloodstream infection is suspected (A II).</li></ul>How should a catheter be sent and processed in the Microbiology Laboratory?Recommendations:<ul class="elsevierStyleList" id="lis0045"><li class="elsevierStyleListItem" id="lsti0090">•The most reliable diagnostic methodologies are the semiquantitative (roll plate) or quantitative (vortex or sonication methods) catheter culture techniques (A-II).</li><li class="elsevierStyleListItem" id="lsti0095">•Qualitative cultures (culture of the catheter tip by broth immersion) are unreliable for distinguishing between contamination and infection and are not therefore suitable for the diagnosis of CRBSI (A-II).</li></ul>How should the results of catheter cultures be interpreted?Recommendations:<ul class="elsevierStyleList" id="lis0050"><li class="elsevierStyleListItem" id="lsti0100">•The presence of 15 CFU per plate or more by semiquantitative culture (roll-plate) is indicative of significant catheter colonization (A-II).</li><li class="elsevierStyleListItem" id="lsti0105">•For quantitative culture methods based on vortexing or flushing the internal surface, a count of 103CFU/segment or more reflects significant catheter colonization (A-II).</li><li class="elsevierStyleListItem" id="lsti0110">•For quantitative culture methods based on sonication, counts above 102 CFU/segment indicate significant catheter colonization (A-II).</li></ul>How should a subcutaneous reservoir be processed?Recommendations:<ul class="elsevierStyleList" id="lis0055"><li class="elsevierStyleListItem" id="lsti0115">•Venous access devices removed for suspected CRBSI should be sent to the microbiology laboratory. Routine processing should include a combination of cultures from different parts of the VAD, including a culture after septum sonication and semiquantitative catheter tip cultures (B-II).</li></ul>What other conservative techniques may be used for diagnosis of CRBSI?Recommendation:<ul class="elsevierStyleList" id="lis0060"><li class="elsevierStyleListItem" id="lsti0120">•Endoluminal brushing of the internal surface of the catheter may be useful for diagnosis of CRBSI. However, the procedure is impractical and major side-effects have been reported (C-III).</li><li class="elsevierStyleListItem" id="lsti0125">•Semiquantitative cultures of skin around the catheter insertion site and catheter hubs with ≥15cfu may be indicative for CRBSI. These procedures must be combined with peripheral blood culture (B-II).</li><li class="elsevierStyleListItem" id="lsti0130">•Gram stain – acridine orange leukocyte cytospin (AOLC) of catheter blood may be used as a rapid method for diagnosis of CRBSI. The presence of any microorganisms in a minimum of 100 high-powered fields may be indicative of CRBSI (B-II).</li></ul>What is the value of molecular techniques for the diagnosis of CRBSI after catheter removal?Recommendation:<ul class="elsevierStyleList" id="lis0065"><li class="elsevierStyleListItem" id="lsti0135">•16S rRNA PCR could be performed with septum sonication fluid to rule out or confirm VAD-RBSI in patients undergoing antibiotic therapy (C-III).</li></ul>Diagnosis of local signs of infectionWhat samples should be taken and how should they be interpreted when an insertion site infection is suspected?Recommendations:<ul class="elsevierStyleList" id="lis0070"><li class="elsevierStyleListItem" id="lsti0140">•When catheter infection is suspected and there is exudate at the catheter insertion site, it should be sent for Gram staining and culture. Blood cultures should also be drawn (A-III).</li><li class="elsevierStyleListItem" id="lsti0145">•In patients with suspected catheter-related infection but negative superficial cultures (growth of <15CFU from both the insertion site and catheter hub cultures), the possibility of infection can reasonably be ruled out (B-II).</li></ul>Catheter related bloodstream infection treatmentWhen can a catheter be retained until blood cultures are available?Recommendation:<ul class="elsevierStyleList" id="lis0075"><li class="elsevierStyleListItem" id="lsti0150">•Immediate removal of the CVC is not routinely recommended when CRBSI is suspected in patients who are hemodynamically stable, without autoimmune diseases or immunosuppressive therapy, intravascular foreign bodies or organ transplants, no suppuration at the insertion site or bacteremia/fungemia (A-I).</li></ul>When is it safe to perform a catheter exchange over a guidewire?Recommendations:<ul class="elsevierStyleList" id="lis0080"><li class="elsevierStyleListItem" id="lsti0155">•Routine replacement of a CVC by guidewire exchange is not recommended because this strategy is associated with a higher risk of infectious complications. (B-II)</li><li class="elsevierStyleListItem" id="lsti0160">•Guidewire exchange of a CVC is contraindicated in patients with documented catheter infections. (A-II)</li><li class="elsevierStyleListItem" id="lsti0165">•Guidewire exchange should be restricted to patients with very difficult venous access (i.e. extensive burns, morbid obesity, or severe coagulopathy) and without documented catheter infection (B-II). In this case, a meticulous aseptic technique and a culture of the catheter tip are mandatory. (A-III)</li><li class="elsevierStyleListItem" id="lsti0170">•If the catheter tip culture is positive, the new line, inserted over a guidewire, should be re-placed via a new direct venipuncture. (C-III)</li></ul>What should be done if the catheter tip culture is positive but the blood cultures are negative?Recommendations:<ul class="elsevierStyleList" id="lis0085"><li class="elsevierStyleListItem" id="lsti0175">•Antibiotic treatment (i.e. 5–7 days) should be given to patients with catheter tip cultures positive for S. aureus and negative blood cultures if the patient shows systemic signs of infection or signs of local infection (B-II).</li><li class="elsevierStyleListItem" id="lsti0180">•In non-neutropenic patients or those without valvular heart disease, the presence of a catheter tip culture positive for Candida spp. and negative or unavailable blood cultures should be assessed on an individual basis before starting systematic antifungal treatment. Antifungal treatment should not be prescribed for patients without systemic signs of infection (B-II).</li><li class="elsevierStyleListItem" id="lsti0185">•No clear recommendations can be given for catheters colonized with other microorganisms (C-III).</li></ul>Empirical antimicrobial therapyWhat is the empirical antimicrobial therapy for CRBSI?Recommendations:<ul class="elsevierStyleList" id="lis0090"><li class="elsevierStyleListItem" id="lsti0190">•If CRBSI is suspected, antimicrobial therapy should be started as soon as possible with a bactericidal agent active against S. aureus and CoNS, especially if associated with sepsis or septic shock (B-II).</li><li class="elsevierStyleListItem" id="lsti0195">•Vancomycin is recommended for empirical therapy in patients with suspected CRBSI (B-II). Teicoplanin is not recommended as empirical therapy, given the existence of coagulase-negative staphylococci with reduced susceptibility to teicoplanin (C-III).</li><li class="elsevierStyleListItem" id="lsti0200">•Daptomycin can be administered for cases of CRBSI with septic shock (C-III), acute kidney injury (B-III), to patients with recent exposure to vancomycin (>1 week in the past 3 months) (C-III) or if the local prevalence of S. aureus isolates with vancomycin MIC≥2.0μg/ml is high (C-III). The local prevalence of S. aureus isolates with vancomycin MIC≥1.5μg/ml supporting routine empirical use of daptomycin remains undefined.</li><li class="elsevierStyleListItem" id="lsti0205">•Linezolid should only be used in patients with contraindications for the previous agents (B-II).</li></ul>When should empirical coverage of Gram-negative bacilli or fungi be added?Recommendations:<ul class="elsevierStyleList" id="lis0095"><li class="elsevierStyleListItem" id="lsti0210">•Patients with suspected CRBSI should receive empirical antibiotic therapy (in addition to coverage for Gram-positive pathogens) to cover Gram-negative bacilli under any of the following circumstances: hemodynamic instability (septic shock), neutropenia or hematologic malignancy, solid organ or bone marrow transplant, femoral catheter in place, a high index of colonization with Gram-negative bacilli or prolonged ICU admission (C-III).</li><li class="elsevierStyleListItem" id="lsti0215">•Antimicrobial therapy should be adapted to local epidemiology and must include an antipseudomonal agent (piperacillin-tazobactam, carbapenems, a fourth-generation cephalosporin, aztreonam, quinolones or aminoglycosides) (A-II). Aztreonam and cephalosporins should be avoided in patients with colonization or at risk for extended-spectrum β-lactamase infections (A-I).</li><li class="elsevierStyleListItem" id="lsti0220">•The need for empirical antifungal therapy in a patient with suspected catheter-related candidemia should be evaluated along with the possibility of catheter removal (A-III).</li><li class="elsevierStyleListItem" id="lsti0225">•Empirical therapy for suspected catheter-related candidemia should be considered in patients who are hemodynamically unstable with one or more of the following conditions: total parenteral nutrition, prolonged use of broad-spectrum antibiotics, malignancy, femoral catheterization, colonization due to Candida species at multiple sites or intense previous anti-anaerobic therapy (C-III).</li><li class="elsevierStyleListItem" id="lsti0230">•The use of biomarkers (such as 1,3-beta-D-glucan) may be useful when considering initiation of empirical treatment (B-III).</li></ul>What particular aspects should be considered in the empirical treatment of CRBSI in patients on hemodialysis?Recommendation:<ul class="elsevierStyleList" id="lis0100"><li class="elsevierStyleListItem" id="lsti0235">•Conservative management of CRBSI should be attempted with hemodialysis patients. Combining systemic and local intracatheter antibiotics is associated with improved results compared to systemic antibiotics alone (A-I).</li><li class="elsevierStyleListItem" id="lsti0240">•In patients with a tunneled hemodialysis catheter, guidewire exchange is an alternative, especially when catheter removal is not feasible (C-III).</li></ul>Targeted antimicrobial therapyWhat is the recommended directed therapy and optimal duration of treatment for CRBSI due toStaphylococcus aureus?Recommendations:<ul class="elsevierStyleList" id="lis0105"><li class="elsevierStyleListItem" id="lsti0245">•The treatment of choice for an episode of MSSA CRBSI is cloxacillin or cefazoline (B-I).</li><li class="elsevierStyleListItem" id="lsti0250">•Patients allergic to beta-lactams should be treated with daptomycin (A-I) or a glycopeptide (B-II).</li><li class="elsevierStyleListItem" id="lsti0255">•The best antimicrobial treatment for episodes caused by MSSA strains with reduced susceptibility to vancomycin (MIC≥1.5mg/L measured by E-test) has not been elucidated. This panel suggests using a combination of cloxacillin and daptomycin when blood cultures remain positive and/or there is no obvious clinical improvement after catheter removal (C-III).</li><li class="elsevierStyleListItem" id="lsti0260">•Vancomycin is the treatment of choice for CRBSI caused by MRSA (B-II). Teicoplanin may be a valid alternative, especially in cases of serious side effects associated with the use of vancomycin. (C-III)</li><li class="elsevierStyleListItem" id="lsti0265">•Alternatively, patients may be treated with daptomycin, specifically if the MIC measured by E-test is ≥1.5mg/L (A-I).</li><li class="elsevierStyleListItem" id="lsti0270">•Linezolid should only be used in patients when the previous agents are contraindicated (C-III).</li><li class="elsevierStyleListItem" id="lsti0275">•In both MSSA and MRSA CRBSI, blood cultures should be obtained after 72h of antibiotic therapy (C-III).</li></ul>What is the recommended directed therapy and optimal duration of treatment for CRBSI due to coagulase-negative Staphylococcus (CoNS)?Recommendations:<ul class="elsevierStyleList" id="lis0110"><li class="elsevierStyleListItem" id="lsti0280">•Cloxacillin or cefazolin are the treatments of choice for episodes of CRBSI caused by CoNS susceptible to methicillin (B-I).</li><li class="elsevierStyleListItem" id="lsti0285">•For CoNS resistant to methicillin, a glycopeptide is the treatment of choice for directed therapy (B-II). Teicoplanin is recommended in the case of serious side effects associated with vancomycin. (C-III).</li><li class="elsevierStyleListItem" id="lsti0290">•The optimal trough concentration of vancomycin for the treatment of CoNS CRBSI is an unresolved issue and this panel cannot issue a specific recommendation (C-III).</li><li class="elsevierStyleListItem" id="lsti0295">•S. lugdunensis CRBSI should be managed as for S aureus CRBSI (C-III).</li></ul>What is the recommended directed therapy and its optimal duration for CRBSI due toEnterococcusspp.?Recommendations:<ul class="elsevierStyleList" id="lis0115"><li class="elsevierStyleListItem" id="lsti0300">•Enterococcal CRBSI should be treated with catheter withdrawal and one active antimicrobial (A-III).</li><li class="elsevierStyleListItem" id="lsti0305">•Ampicillin is the drug of choice for susceptible isolates (A-II). Vancomycin should be reserved for isolates resistant to ampicillin or cases of beta-lactam allergy. For vancomycin-resistant isolates or severe adverse effects, linezolid is preferred to daptomycin (B-III).</li><li class="elsevierStyleListItem" id="lsti0310">•There is no evidence that combination therapy is necessary if IE has been properly ruled out (A-III).</li><li class="elsevierStyleListItem" id="lsti0315">•Despite data suggesting that duration of treatment may be shorter, the standard 7–14 day regimen continues to be recommended (A-III).</li></ul>What is the recommended directed therapy and its optimal duration for CRBSI due to Gram-negative bacilli?Recommendations:<ul class="elsevierStyleList" id="lis0120"><li class="elsevierStyleListItem" id="lsti0320">•Directed therapy for GN-CRBSI should be chosen on the basis of the susceptibility results (C-III).</li><li class="elsevierStyleListItem" id="lsti0325">•The appropriate length of antimicrobial therapy has not been elucidated, although it is recommended to continue therapy for at least 7 days (C-II).</li></ul>What is the recommended directed therapy and its optimal duration for CRBSI due toCandidaspp.?Recommendations:<ul class="elsevierStyleList" id="lis0125"><li class="elsevierStyleListItem" id="lsti0330">•In patients with Candida spp CRBSI, this panel advocates de-escalation from an echinocandin or a lipid formulation of amphotericin B to fluconazole for susceptible isolates in clinically stable patients who have undergone catheter removal (B-II).</li><li class="elsevierStyleListItem" id="lsti0335">•The recommended duration of therapy for candidemia without obvious metastatic complications is two weeks after the first set of negative blood cultures (B-III).</li><li class="elsevierStyleListItem" id="lsti0340">•In candidemia, all intravascular catheters should be removed if at all feasible (B-II), particularly in patients with septic shock and Candida CRBSI is suspected (B-III).</li><li class="elsevierStyleListItem" id="lsti0345">•If a catheter that is the source of a Candida bloodstream infection cannot be removed for any reason and remains in place, an antifungal agent with high activity against biofilms should be used (i.e. an echinocandin or liposomal amphotericin B) (A-II).</li></ul>What is the recommended directed therapy and its optimal duration for CRBSI due to nontuberculous mycobacteria (NTM)?Recommendations:<ul class="elsevierStyleList" id="lis0130"><li class="elsevierStyleListItem" id="lsti0350">•The treatment for CRBSI caused by NTM involves removal of the infected catheter (B-II) followed by combination antimicrobial treatment appropriate for the species involved (B-III).</li><li class="elsevierStyleListItem" id="lsti0355">•The duration of treatment for NTM CRBSI should be 6–12 weeks to prevent recurrence of infection and the development of septic metastases (B-III).</li></ul>Should antimicrobials for CRSBI be administered intravenously for the entire course of treatment?Recommendations:<ul class="elsevierStyleList" id="lis0135"><li class="elsevierStyleListItem" id="lsti0360">•Sequential oral therapy can be considered in clinically stable patients without metastatic complications and with negative blood cultures after onset of treatment and removal of the intravenous line, if a therapeutic option with high oral bioavailability is available (A-II).</li><li class="elsevierStyleListItem" id="lsti0365">•In uncomplicated CRBSI caused by fluoroquinolone-susceptible staphylococci, initial intravenous antibiotic treatment may be switched to high-dose oral fluoroquinolones plus rifampicin in order to complete the course of antibiotic therapy if the patient is clinically stable and clearance of bacteremia is documented. Linezolid could be an option if the microorganism involved is fluorquinolone-resistant (A-II).</li><li class="elsevierStyleListItem" id="lsti0370">•In uncomplicated CRBSI caused by fluoroquinolone-susceptible Gram-negative bacilli, initial intravenous antibiotic treatment may be switched to high-dose oral fluoroquinolones in order to complete the course of antibiotic therapy if the patient is clinically stable and clearance of bacteremia is documented (A-II).</li><li class="elsevierStyleListItem" id="lsti0375">•A step-down from an echinocandin or lipid formulation of amphotericin B to oral fluconazole is safe and effective (C-III).</li></ul>Conservative treatment: antibiotic lock therapy (ALT)When is conservative management with antibiotic lock therapy recommended?Recommendation:<ul class="elsevierStyleList" id="lis0140"><li class="elsevierStyleListItem" id="lsti0380">•Conservative treatment should not be prescribed for patients with metastatic or local septic complications (A-II).</li><li class="elsevierStyleListItem" id="lsti0385">•The use of lock therapy added to systemic antimicrobial agents is systematically recommended for infected catheters that fulfill the criteria for catheter retention: the patient is stable and the microorganism involved is considered to be of low virulence (i.e. CoNS) (A-I).</li><li class="elsevierStyleListItem" id="lsti0390">•In stable patients without local or systemic complications, conservative treatment may also be attempted for enterococci, corynebacterium (except Corynebacterium jeikeium) and Gram-negatives (consultation with an ID expert is suggested in such cases) (C-III).</li><li class="elsevierStyleListItem" id="lsti0395">•The use of an antibiotic lock does not preclude the need for systemic antimicrobial therapy (A-I).</li></ul>What antibiotics and concentrations of antibiotic lock solutions are recommended?Recommendation:<ul class="elsevierStyleList" id="lis0145"><li class="elsevierStyleListItem" id="lsti0400">•The most frequently used antibiotics for conservative treatment of CRBSI using ALT are vancomycin 2000mg/L, teicoplanin 10,000mg/L, daptomycin 5000mg/L, ciprofloxacin 2000mg/L, and amikacin 2000mg/L (B-I).</li></ul>How should antibiotic lock therapy be performed?Recommendation:<ul class="elsevierStyleList" id="lis0150"><li class="elsevierStyleListItem" id="lsti0405">•An ALT solution should be prepared under sterile conditions. It should be infused after removing the previous dose and the exact volume of the catheter lumen should be infused. The recommended duration of ALT is 10–14 days. The ALT solution must remain in the catheter lumen for a minimum of 12h a day and should be replaced every 24–72h (B-I).</li></ul>What non-antibiotic substances could be used for lock therapy?Recommendations:<ul class="elsevierStyleList" id="lis0155"><li class="elsevierStyleListItem" id="lsti0410">•70% ethanol and taurolidine locks can also be used for the conservative treatment of CRBSI. There is no evidence to advocate for their routine use (B-I).</li></ul>What are the criteria for failure of conservative management?Recommendation:<ul class="elsevierStyleList" id="lis0160"><li class="elsevierStyleListItem" id="lsti0415">•Any clinical condition or catheter dysfunction prompting catheter removal should be considered failure of conservative management (A-I).</li></ul>Management of local complicationsHow should insertion site infection be managed?Recommendations:<ul class="elsevierStyleList" id="lis0165"><li class="elsevierStyleListItem" id="lsti0420">•For peripheral venous catheters, catheter removal is mandatory if there is local pain, induration, erythema or exudate (A-I).</li><li class="elsevierStyleListItem" id="lsti0425">•For non-tunneled CVCs, the presence of erythema or purulence at the catheter insertion site requires immediate catheter removal (B-II).</li><li class="elsevierStyleListItem" id="lsti0430">•For uncomplicated exit site infections with long-term catheters, a conservative approach with topical antimicrobial agents should first be attempted. In cases of topical treatment failure, systemic antibiotics should be administered (B-III).</li><li class="elsevierStyleListItem" id="lsti0435">•Persistence of clinical signs of infection beyond 72h of conservative management requires removal of the catheter (B-II).</li></ul>How should tunnelitis be managed?Recommendations:<ul class="elsevierStyleList" id="lis0170"><li class="elsevierStyleListItem" id="lsti0440">•Patients with tunnel infection not associated with a hemodialysis catheter require catheter removal, incision and drainage, if indicated, and 7–10 days of systemic antimicrobial therapy in the absence of concomitant bacteremia or candidemia (A-II).</li><li class="elsevierStyleListItem" id="lsti0445">•For tunnelitis without fever in hemodialysis catheters, systemic antibiotic therapy may be attempted first (A-II). In tunnel infection with fever, catheter removal is the first therapeutic option together with systemic antimicrobial therapy (A-II).</li><li class="elsevierStyleListItem" id="lsti0450">•In tunnelitis, conservative management is associated with higher failure rates (B-II).</li></ul>How should a local infection associated with a port reservoir be managed?Recommendations:<ul class="elsevierStyleList" id="lis0175"><li class="elsevierStyleListItem" id="lsti0455">•In the presence of signs of local inflammation at a port reservoir, the port must be removed, the affected tissue drained and systemic antibiotic therapy started (A-II).</li><li class="elsevierStyleListItem" id="lsti0460">•If a conservative strategy is the only option, a combination of systemic antibiotics and antibiotic lock therapy should be prescribed, bearing in mind that this approach is associated with a high failure rate (B-II).</li></ul>Patient follow-upIn which patients and when should a follow-up blood culture be taken?Recommendations:<ul class="elsevierStyleList" id="lis0180"><li class="elsevierStyleListItem" id="lsti0465">•Follow-up blood cultures should be taken from all patients with S. aureus or Candida spp CRBSI (A-II).</li><li class="elsevierStyleListItem" id="lsti0470">•In patients with S. aureus CRBSI, we recommend that follow-up blood cultures should be obtained every 72h until the first negative result (A-II).</li><li class="elsevierStyleListItem" id="lsti0475">•Control blood cultures in CRBSI due to Candida spp should be obtained every 48h until the first negative blood culture (A-II).</li><li class="elsevierStyleListItem" id="lsti0480">•For other causative microorganisms of CRBSI and if catheter salvage is attempted, follow-up blood cultures should be obtained 72h after starting appropriate antibiotic therapy. If persistent bacteremia is documented, catheter removal is required (B-II).</li><li class="elsevierStyleListItem" id="lsti0485">•It is not necessary to routinely perform follow-up blood cultures in patients with CRBSI due to microorganisms other than S. aureus or Candida spp if the catheter has been withdrawn (A-II).</li></ul>When should echocardiography be performed?Recommendations:<ul class="elsevierStyleList" id="lis0185"><li class="elsevierStyleListItem" id="lsti0490">•TEE should be performed in the vast majority of patients with Staphylococcus aureus bacteremia. TEE is not necessary or can be delayed in patients without the following risk factors: prolonged bacteremia, hemodialysis, metastatic foci of infection, IVDA, implantable CVC, intracardiac device, prosthetic valve, previous IE or cardiac structural abnormality (A-II).</li><li class="elsevierStyleListItem" id="lsti0495">•The need for TEE in episodes of CRBSI caused by other pathogens should be individualized. This panel considers that IE should be ruled out in all patients with persistent bacteremia (or fungemia) (C-III). Enterococcus spp and Candida spp pathogens are associated with a high risk of developing endocarditis.</li></ul>What is the diagnosis and management for w?Recommendation:<ul class="elsevierStyleList" id="lis0190"><li class="elsevierStyleListItem" id="lsti0500">•Suppurative thrombophlebitis should be ruled out in all episodes of CRBSI with persistent bacteremia (A-II).</li><li class="elsevierStyleListItem" id="lsti0505">•Confirmed diagnosis, mainly by ultrasonography, should be followed by catheter withdrawal, prolonged antibiotic treatment and an individualized assessment of the need for anticoagulation (A-II).</li></ul>When can a new catheter be inserted?Recommendation:<ul class="elsevierStyleList" id="lis0195"><li class="elsevierStyleListItem" id="lsti0510">•Although there is a clear lack of scientific evidence, it seems advisable to wait, if feasible, before placing a new catheter after an episode of CRBSI. The waiting period should be determined by the resolution of signs and symptoms. If a patient urgently needs vascular access, a catheter should be inserted without delay (C-III).</li><li class="elsevierStyleListItem" id="lsti0515">•Insertion of a new catheter after a diagnosis of CRBSI is always possible if the patient's clinical condition dictates the need for a new vascular access (A-III).</li></ul>Conflict of interestsJaime Esteban has participated in counseling and lectures at meetings sponsored by Laboratorios Leti SL in the last year, as well as received grants for research and teaching from laboratories Pfizer, Sysmex, Angelini and bioMérieux.Paula Ramirez has participated in counseling and lectures at meetings sponsored by Pfizer, MSD, Astellas, Gilead and Otsuka in the last year, as well as received grants for research and teaching at Otsuka laboratories.Jose Luis del Pozo has lectured at meetings sponsored by Pfizer, MSD and Angelini Laboratories.Miguel Salavert has participated in counseling and lectures at meetings sponsored by MSD, Pfizer, Gilead, Astellas Ph and Angelini in the last year, as well as received grants for research and teaching from Janssen and ViiV laboratories.José Ramón Paño has participated in counseling and lectures at meetings sponsored by Janssen, Gilead and MSD in the last year.José Garnacho-Montero has participated in conferences sponsored by MSD and Astellas.Emilio Bouza has participated in advisory services and lectures sponsored by MSD, Pfizer and Astellas in the last year.The rest of the authors declare that they have no conflicts of interest." "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:3 [ "identificador" => "xres975357" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec945180" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres975358" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec945181" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction: justification and aims" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Methods" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "General aspects" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Diagnosis without catheter withdrawal (conservative diagnosis)" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Diagnosis of CRBI with catheter withdrawal" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Diagnosis of local signs of infection" ] ] ] 6 => array:3 [ "identificador" => "sec0035" "titulo" => "Catheter related bloodstream infection treatment" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0040" "titulo" => "Empirical antimicrobial therapy" ] 1 => array:2 [ "identificador" => "sec0045" "titulo" => "Targeted antimicrobial therapy" ] 2 => array:2 [ "identificador" => "sec0050" "titulo" => "Conservative treatment: antibiotic lock therapy (ALT)" ] 3 => array:2 [ "identificador" => "sec0055" "titulo" => "Management of local complications" ] 4 => array:2 [ "identificador" => "sec0060" "titulo" => "Patient follow-up" ] ] ] 7 => array:2 [ "identificador" => "sec0065" "titulo" => "Conflict of interests" ] 8 => array:2 [ "identificador" => "xack330739" "titulo" => "Acknowledgments" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec945180" "palabras" => array:5 [ 0 => "Catheter-related bloodstream infection" 1 => "Guidelines" 2 => "Bacteremia" 3 => "Blood cultures" 4 => "Antibiotic" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec945181" "palabras" => array:5 [ 0 => "Bacteriemia relacionada con catéter" 1 => "Guía de práctica clínica" 2 => "Bacteriemia" 3 => "Hemocultivos" 4 => "Antibioterapia" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "Catheter-related bloodstream infections (CRBSI) constitute an important cause of hospital-acquired infection associated with morbidity, mortality, and cost. The aim of these guidelines is to provide updated recommendations for the diagnosis and management of CRBSI in adults. Prevention of CRBSI is excluded. Experts in the field were designated by the two participating Societies (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica and the Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias). Short-term peripheral venous catheters, non-tunneled and long-term central venous catheters, tunneled catheters and hemodialysis catheters are covered by these guidelines. The panel identified 39 key topics that were formulated in accordance with the PICO format. The strength of the recommendations and quality of the evidence were graded in accordance with ESCMID guidelines. Recommendations are made for the diagnosis of CRBSI with and without catheter removal and of tunnel infection. The document establishes the clinical situations in which a conservative diagnosis of CRBSI (diagnosis without catheter removal) is feasible. Recommendations are also made regarding empirical therapy, pathogen-specific treatment (coagulase-negative staphylococci, Sthaphylococcus aureus, Enterococcus spp, Gram-negative bacilli, and Candida spp), antibiotic lock therapy, diagnosis and management of suppurative thrombophlebitis and local complications." ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "La bacteriemia relacionada con catéteres (BRC) constituye una causa importante de infección hospitalaria y se asocia con elevada morbilidad, mortalidad y costo. El objetivo de esta guía de práctica clínica es proporcionar recomendaciones actualizadas para el diagnóstico y el tratamiento de la BRC en pacientes adultos. De este documento se excluye la prevención de la BRC. Expertos en la materia fueron designados por las 2 sociedades participantes (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica y Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias). Los catéteres venosos periféricos a corto plazo, los catéteres venosos centrales no tunelizados y de largo plazo, los catéteres tunelizados y los catéteres de hemodiálisis están incluidos por estas guías. El panel identificó 39 temas claves que fueron formulados de acuerdo con el formato PICO. La fuerza de las recomendaciones y la calidad de la evidencia se clasificaron de acuerdo con las directrices de la ESCMID. Se hacen recomendaciones para el diagnóstico de BRC con y sin extracción de catéter y de la infección en túnel. El documento establece las situaciones clínicas en las que es factible un diagnóstico conservador de CRBSI (diagnóstico sin retirada de catéter). También se hacen recomendaciones con respecto a la terapia empírica, el tratamiento específico según el patógeno identificado (estafilococos coagulasa negativos, Staphylococcus aureus, Enterococcus spp, bacilos gramnegativos y Candida spp), la terapia con sellado del catéter, el diagnóstico, así como el tratamiento de la tromboflebitis supurativa y las complicaciones locales." ] ] "NotaPie" => array:2 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "The consensus statement is available at: https://www.seimc.org/contenidos/documentoscientificos/guiasclinicas/seimc-guiasclinicas-2017-Catheter-Related_Bloodstream_Infection.pdf and as additional material in the journal official website." ] 1 => array:2 [ "etiqueta" => "☆☆" "nota" => "The complete consensus statement has also been published in: Medicina Intensiva. 2017. http://dx.doi.org/10.1016/10.1016/j.medin.2017.09.012" ] ] "apendice" => array:1 [ 0 => array:1 [ "seccion" => array:1 [ 0 => array:4 [ "apendice" => "The following are the supplementary data to this article:<elsevierMultimedia ident="upi0005"></elsevierMultimedia>" "etiqueta" => "Appendix B" "titulo" => "Supplementary data" "identificador" => "sec0080" ] ] ] ] "multimedia" => array:2 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Category/grading strength of recommendations \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Definition \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">A \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Strongly supports a recommendation for use \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">B \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Moderately supports a recommendation for use \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">C \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Marginally supports a recommendation for use \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">D \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Supports a recommendation against use \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top">Quality of evidence</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">I \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Evidence from at least one properly designed randomized, controlled trial \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">II \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Evidence from at least one well-designed clinical trial, without randomization; from cohort or case-controlled analytic studies (preferably from 1 center); from multiple time series; or from dramatic results of uncontrolled experiments \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">III \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Evidence from opinions of respected authorities, based on clinical experience, descriptive case studies \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1651635.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Strength of recommendation and quality of evidence." ] ] 1 => array:5 [ "identificador" => "upi0005" "tipo" => "MULTIMEDIAECOMPONENTE" "mostrarFloat" => false "mostrarDisplay" => true "Ecomponente" => array:2 [ "fichero" => "mmc1.pdf" "ficheroTamanyo" => 548250 ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:7 [ 0 => array:3 [ "identificador" => "bib0040" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "EPINE 2015. INFORME GLOBAL DE ESPAÑA. RESUMEN – EPINE 2015 INFORME GLOBAL DE ESPAÑA RESUMEN.pdf [Internet]. Available from: <a href="http://hws.vhebron.net/epine/Descargas/EPINE%202015%20INFORME%20GLOBAL%20DE%20ESPA%C3%91A%20RESUMEN.pdf">http://hws.vhebron.net/epine/Descargas/EPINE%202015%20INFORME%20GLOBAL%20DE%20ESPA%C3%91A%20RESUMEN.pdf</a> [accessed 19.11.16]." ] ] ] 1 => array:3 [ "identificador" => "bib0045" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "[Infections related to intravascular devices used for infusion therapy]" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J. Fortún" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Enferm Infecc Microbiol Clin" "fecha" => "2008" "volumen" => "26" "paginaInicial" => "168" "paginaFinal" => "174" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18358216" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0050" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Rodríguez-Baño" 1 => "M.D. López-Prieto" 2 => "M.M. Portillo" 3 => "P. Retamar" 4 => "C. Natera" 5 => "E. Nuño" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1469-0691.2009.03089.x" "Revista" => array:6 [ "tituloSerie" => "Clin Microbiol Infect" "fecha" => "2010" "volumen" => "16" "paginaInicial" => "1408" "paginaFinal" => "1413" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19845694" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0055" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "[Costs associated with nosocomial bacteraemias in a University Hospital]" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Riu" 1 => "R. Terradas" 2 => "M. Sala" 3 => "M. Comas" 4 => "H. Knobel" 5 => "S. Grau" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.eimc.2011.11.006" "Revista" => array:6 [ "tituloSerie" => "Enferm Infecc Microbiol Clin" "fecha" => "2012" "volumen" => "30" "paginaInicial" => "137" "paginaFinal" => "142" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22206947" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0060" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Morbidity and mortality associated with primary and catheter-related bloodstream infections in critically ill patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.M. Olaechea" 1 => "M. Palomar" 2 => "F. Álvarez-Lerma" 3 => "J.J. Otal" 4 => "J. Insausti" 5 => "M.J. López-Pueyo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Esp Quimioter" "fecha" => "2013" "volumen" => "26" "paginaInicial" => "21" "paginaFinal" => "29" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23546458" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0065" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intravascular catheter-related infections: advances in diagnosis, prevention, and management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "I. Raad" 1 => "H. Hanna" 2 => "D. Maki" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1473-3099(07)70235-9" "Revista" => array:6 [ "tituloSerie" => "Lancet Infect Dis" "fecha" => "2007" "volumen" => "7" "paginaInicial" => "645" "paginaFinal" => "657" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17897607" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0070" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "[Guidelines for the treatment of short-term intravascular catheter-related infections in adults; SEIMC-SEMICYUC Consensus Conference]" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "SEIMC, SEMICYUC" "etal" => false "autores" => array:2 [ 0 => "C. León" 1 => "J. Ariza" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Enferm Infecc Microbiol Clin" "fecha" => "2004" "volumen" => "22" "paginaInicial" => "92" "paginaFinal" => "101" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14756991" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack330739" "titulo" => "Acknowledgments" "texto" => "The authors thank Dr. Antonio Gutiérrez-Pizarraya for his commentaries and technical support for the elaboration of this document." "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/0213005X/0000003600000002/v2_201802071725/S0213005X17303130/v2_201802071725/en/main.assets" "Apartado" => array:4 [ "identificador" => "8681" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Documento de consenso" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/0213005X/0000003600000002/v2_201802071725/S0213005X17303130/v2_201802071725/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X17303130?idApp=UINPBA00004N"]

Statistics

Consensus statement

Executive summary: Diagnosis and Treatment of Catheter-Related Bloodstream Infection: Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC)

Resumen ejecutivo del documento de consenso sobre diagnóstico y tratamiento de la bacteriemia relacionada con catéter: Guía de Práctica Clínica de la Sociedad Española de Enfermedades Infecciosas (SEIMC) y de la Sociedad Española de Medicina Intensiva Crítica y Unidades Coronarias (SEMICYUC)

Fernando Chavesa, José Garnacho-Monterob, José Luis del Pozoc,

Corresponding author

jdelpozo@unav.es

Corresponding author.

, Emilio Bouzad, José Antonio Capdevilae, Marina de Cuetof, M. Ángeles Domínguezg, Jaime Estebanh, Nuria Fernández-Hidalgoi, Marta Fernández Sampedroj, Jesús Fortúnk, María Guembel, Leonardo Lorentem, Jose Ramón Pañon, Paula Ramírezo, Miguel Salavertp, Miguel Sánchezq, Jordi Vallésr

a Servicio de Microbiología, Hospital Universitario 12 de Octubre, Madrid, España

b Unidad Clínica de Cuidados Intensivos, Hospital Universitario Virgen Macarena, Sevilla, España

c Área de Enfermedades Infecciosas, Servicio de Microbiología, Clínica Universidad de Navarra, Pamplona, España

d Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid; CIBER de Enfermedades Respiratorias, CibeRes, Instituto de Salud Carlos III, Madrid; Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España

e Servicio de Medicina Interna, Hospital de Mataró, Mataró, Barcelona, España

f Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Sevilla, España

g Servicio de Microbiología, Hospital Universitari de Bellvitge, IDIBELL, L’Hospitalet de Llobregat, Barcelona, España

h Departamento de Microbiología Clínica, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, España

i Servei de Malalties Infeccioses, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, España

j Servicio de Enfermedades Infecciosas, Hospital Universitario Marqués de Valdecilla, Santander, España

k Unidad de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, Madrid, España

l Unidad de Enfermedades Infecciosas y Microbiología Clínica, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, España

m Unidad de Cuidados Intensivos, Hospital Universitario de Canarias, Santa Cruz de Tenerife, España

n Unidad de Enfermedades Infecciosas, Hospital Clínico Universitario Lozano Blesa, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, España

o Unidad de Cuidados Intensivos, Hospital Universitari i Politècnic La Fe, Valencia; CIBER de Enfermedades Respiratorias (CibeRes), Instituto de Salud Carlos III, Madrid, España

p Unidad de Enfermedades Infecciosas, Hospital Universitari i Politècnic La Fe, Valencia, España

q Servicio de Medicina Intensiva, Hospital Clínico San Carlos, Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España

r Unidad de Cuidados Intensivos, Hospital Universitari Parc Taulí, Sabadell, Barcelona; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, España

Read

12367

Times
was read the article

3708

Total PDF

8659

Total HTML

Share statistics

 array:24 [
  "pii" => "S0213005X17303130"
  "issn" => "0213005X"
  "doi" => "10.1016/j.eimc.2017.10.019"
  "estado" => "S300"
  "fechaPublicacion" => "2018-02-01"
  "aid" => "1771"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Enfermedades Infecciosas y Microbiolog&#237;a Cl&#237;nica"
  "copyrightAnyo" => "2017"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "pgl"
  "cita" => "Enferm Infecc Microbiol Clin. 2018;36:112-9"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 2710
    "formatos" => array:2 [
      "HTML" => 1945
      "PDF" => 765
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S2529993X18300431"
      "issn" => "2529993X"
      "doi" => "10.1016/j.eimce.2017.10.013"
      "estado" => "S300"
      "fechaPublicacion" => "2018-02-01"
      "aid" => "1771"
      "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Enfermedades Infecciosas y Microbiolog&#237;a Cl&#237;nica"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "pgl"
      "cita" => "Enferm Infecc Microbiol Clin. 2018;36:112-9"
      "abierto" => array:3 [
        "ES" => false
        "ES2" => false
        "LATM" => false
      ]
      "gratuito" => false
      "lecturas" => array:2 [
        "total" => 468
        "formatos" => array:2 [
          "HTML" => 311
          "PDF" => 157
        ]
      ]
      "en" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Consensus statement</span>"
        "titulo" => "Executive summary&#58; Diagnosis and Treatment of Catheter-Related Bloodstream Infection&#58; Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases &#40;SEIMC&#41; and the Spanish Society of Intensive Care Medicine and Coronary Units &#40;SEMICYUC&#41;"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "en"
          1 => "es"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "112"
            "paginaFinal" => "119"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Resumen ejecutivo del documento de consenso sobre diagn&#243;stico y tratamiento de la bacteriemia relacionada con cat&#232;c&#41;ter&#58; Gu&#237;a de Pr&#225;ctica Cl&#237;nica de la Sociedad Espa&#241;ola de Enfermedades Infecciosas &#40;SEIMC&#41; y de la Sociedad Espa&#241;ola de Medicina Intensiva Cr&#237;tica y Unidades Coronarias &#40;SEMICYUC&#41;"
          ]
        ]
        "contieneResumen" => array:2 [
          "en" => true
          "es" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Fernando Chaves, Jos&#232;c&#41; Garnacho-Montero, Jos&#232;c&#41; Luis del Pozo, Emilio Bouza, Jos&#232;c&#41; Antonio Capdevila, Marina de Cueto, M&#46; &#193;ngeles Dom&#237;nguez, Jaime Esteban, Nuria Fern&#225;ndez-Hidalgo, Marta Fern&#225;ndez Sampedro, Jes&#250;s Fort&#250;n, Mar&#237;a Guembe, Leonardo Lorente, Jose Ram&#243;n Pa&#241;o, Paula Ram&#237;rez, Miguel Salavert, Miguel S&#225;nchez, Jordi Vall&#232;c&#41;s"
            "autores" => array:18 [
              0 => array:2 [
                "nombre" => "Fernando"
                "apellidos" => "Chaves"
              ]
              1 => array:2 [
                "nombre" => "Jos&#232;c&#41;"
                "apellidos" => "Garnacho-Montero"
              ]
              2 => array:2 [
                "nombre" => "Jos&#232;c&#41; Luis"
                "apellidos" => "del Pozo"
              ]
              3 => array:3 [
                "preGrado" => "Authors&#58;"
                "nombre" => "Emilio"
                "apellidos" => "Bouza"
              ]
              4 => array:2 [
                "nombre" => "Jos&#232;c&#41; Antonio"
                "apellidos" => "Capdevila"
              ]
              5 => array:2 [
                "nombre" => "Marina"
                "apellidos" => "de Cueto"
              ]
              6 => array:2 [
                "nombre" => "M&#46; &#193;ngeles"
                "apellidos" => "Dom&#237;nguez"
              ]
              7 => array:2 [
                "nombre" => "Jaime"
                "apellidos" => "Esteban"
              ]
              8 => array:2 [
                "nombre" => "Nuria"
                "apellidos" => "Fern&#225;ndez-Hidalgo"
              ]
              9 => array:2 [
                "nombre" => "Marta"
                "apellidos" => "Fern&#225;ndez Sampedro"
              ]
              10 => array:2 [
                "nombre" => "Jes&#250;s"
                "apellidos" => "Fort&#250;n"
              ]
              11 => array:2 [
                "nombre" => "Mar&#237;a"
                "apellidos" => "Guembe"
              ]
              12 => array:2 [
                "nombre" => "Leonardo"
                "apellidos" => "Lorente"
              ]
              13 => array:2 [
                "nombre" => "Jose Ram&#243;n"
                "apellidos" => "Pa&#241;o"
              ]
              14 => array:2 [
                "nombre" => "Paula"
                "apellidos" => "Ram&#237;rez"
              ]
              15 => array:2 [
                "nombre" => "Miguel"
                "apellidos" => "Salavert"
              ]
              16 => array:2 [
                "nombre" => "Miguel"
                "apellidos" => "S&#225;nchez"
              ]
              17 => array:2 [
                "nombre" => "Jordi"
                "apellidos" => "Vall&#232;c&#41;s"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S0213005X17303130"
          "doi" => "10.1016/j.eimc.2017.10.019"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X17303130?idApp=UINPBA00004N"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X18300431?idApp=UINPBA00004N"
      "url" => "/2529993X/0000003600000002/v2_201802191141/S2529993X18300431/v2_201802191141/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0213005X15004577"
    "issn" => "0213005X"
    "doi" => "10.1016/j.eimc.2015.11.019"
    "estado" => "S300"
    "fechaPublicacion" => "2018-02-01"
    "aid" => "1461"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and Sociedad Espa&#241;ola de Enfermedades Infecciosas y Microbiolog&#237;a Cl&#237;nica"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "ssu"
    "cita" => "Enferm Infecc Microbiol Clin. 2018;36:120-36"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 2623
      "formatos" => array:3 [
        "EPUB" => 2
        "HTML" => 2103
        "PDF" => 518
      ]
    ]
    "es" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Revisi&#243;n</span>"
      "titulo" => "Helmintosis y eosinofilia en Espa&#241;a &#40;1990-2015&#41;"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "120"
          "paginaFinal" => "136"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Helminthosis and eosinophilia in Spain &#40;1990-2015&#41;"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figura 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 1632
              "Ancho" => 2333
              "Tamanyo" => 225596
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Provincias con casos publicados de anisakidosis &#40;1990-2015&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Cristina Carranza-Rodr&#237;guez, Miriam Escamilla-Gonz&#225;lez, Isabel Fuentes-Corripio, Mar&#237;a-Jes&#250;s Perteguer-Prieto, Teresa G&#225;rate-Ormaechea, Jos&#233;-Luis P&#233;rez-Arellano"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Cristina"
              "apellidos" => "Carranza-Rodr&#237;guez"
            ]
            1 => array:2 [
              "nombre" => "Miriam"
              "apellidos" => "Escamilla-Gonz&#225;lez"
            ]
            2 => array:2 [
              "nombre" => "Isabel"
              "apellidos" => "Fuentes-Corripio"
            ]
            3 => array:2 [
              "nombre" => "Mar&#237;a-Jes&#250;s"
              "apellidos" => "Perteguer-Prieto"
            ]
            4 => array:2 [
              "nombre" => "Teresa"
              "apellidos" => "G&#225;rate-Ormaechea"
            ]
            5 => array:2 [
              "nombre" => "Jos&#233;-Luis"
              "apellidos" => "P&#233;rez-Arellano"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2529993X18300066"
        "doi" => "10.1016/j.eimce.2015.11.002"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X18300066?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X15004577?idApp=UINPBA00004N"
    "url" => "/0213005X/0000003600000002/v2_201802071725/S0213005X15004577/v2_201802071725/es/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S0213005X17303695"
    "issn" => "0213005X"
    "doi" => "10.1016/j.eimc.2017.11.009"
    "estado" => "S300"
    "fechaPublicacion" => "2018-02-01"
    "aid" => "1787"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Enferm Infecc Microbiol Clin. 2018;36:104-11"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 5325
      "formatos" => array:3 [
        "EPUB" => 2
        "HTML" => 4017
        "PDF" => 1306
      ]
    ]
    "es" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Formaci&#243;n m&#233;dica continuada&#58; infecciones por micobacterias</span>"
      "titulo" => "Diagn&#243;stico microbiol&#243;gico de las infecciones causadas por el g&#233;nero <span class="elsevierStyleItalic">Mycobacterium</span>"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "104"
          "paginaFinal" => "111"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Microbiological diagnosis of infections caused by the genus <span class="elsevierStyleItalic">Mycobacterium</span>"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Sof&#237;a Samper, Juli&#224; Gonz&#225;lez-Martin"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "Sof&#237;a"
              "apellidos" => "Samper"
            ]
            1 => array:2 [
              "nombre" => "Juli&#224;"
              "apellidos" => "Gonz&#225;lez-Martin"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2529993X18300194"
        "doi" => "10.1016/j.eimce.2017.11.018"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => false
          "ES2" => false
          "LATM" => false
        ]
        "gratuito" => false
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X18300194?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X17303695?idApp=UINPBA00004N"
    "url" => "/0213005X/0000003600000002/v2_201802071725/S0213005X17303695/v2_201802071725/es/main.assets"
  ]
  "en" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Consensus statement</span>"
    "titulo" => "Executive summary&#58; Diagnosis and Treatment of Catheter-Related Bloodstream Infection&#58; Clinical Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases &#40;SEIMC&#41; and the Spanish Society of Intensive Care Medicine and Coronary Units &#40;SEMICYUC&#41;"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "112"
        "paginaFinal" => "119"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Fernando Chaves, Jos&#233; Garnacho-Montero, Jos&#233; Luis del Pozo, Emilio Bouza, Jos&#233; Antonio Capdevila, Marina de Cueto, M&#46; &#193;ngeles Dom&#237;nguez, Jaime Esteban, Nuria Fern&#225;ndez-Hidalgo, Marta Fern&#225;ndez Sampedro, Jes&#250;s Fort&#250;n, Mar&#237;a Guembe, Leonardo Lorente, Jose Ram&#243;n Pa&#241;o, Paula Ram&#237;rez, Miguel Salavert, Miguel S&#225;nchez, Jordi Vall&#233;s"
        "autores" => array:18 [
          0 => array:3 [
            "nombre" => "Fernando"
            "apellidos" => "Chaves"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff1"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Jos&#233;"
            "apellidos" => "Garnacho-Montero"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:4 [
            "nombre" => "Jos&#233; Luis"
            "apellidos" => "del Pozo"
            "email" => array:1 [
              0 => "jdelpozo&#64;unav&#46;es"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          3 => array:4 [
            "preGrado" => "Authors&#58;"
            "nombre" => "Emilio"
            "apellidos" => "Bouza"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Jos&#233; Antonio"
            "apellidos" => "Capdevila"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "aff0025"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Marina"
            "apellidos" => "de Cueto"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">f</span>"
                "identificador" => "aff0030"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "M&#46; &#193;ngeles"
            "apellidos" => "Dom&#237;nguez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">g</span>"
                "identificador" => "aff0035"
              ]
            ]
          ]
          7 => array:3 [
            "nombre" => "Jaime"
            "apellidos" => "Esteban"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">h</span>"
                "identificador" => "aff0040"
              ]
            ]
          ]
          8 => array:3 [
            "nombre" => "Nuria"
            "apellidos" => "Fern&#225;ndez-Hidalgo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">i</span>"
                "identificador" => "aff0045"
              ]
            ]
          ]
          9 => array:3 [
            "nombre" => "Marta"
            "apellidos" => "Fern&#225;ndez Sampedro"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">j</span>"
                "identificador" => "aff0050"
              ]
            ]
          ]
          10 => array:3 [
            "nombre" => "Jes&#250;s"
            "apellidos" => "Fort&#250;n"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">k</span>"
                "identificador" => "aff0055"
              ]
            ]
          ]
          11 => array:3 [
            "nombre" => "Mar&#237;a"
            "apellidos" => "Guembe"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">l</span>"
                "identificador" => "aff0060"
              ]
            ]
          ]
          12 => array:3 [
            "nombre" => "Leonardo"
            "apellidos" => "Lorente"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">m</span>"
                "identificador" => "aff0065"
              ]
            ]
          ]
          13 => array:3 [
            "nombre" => "Jose Ram&#243;n"
            "apellidos" => "Pa&#241;o"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">n</span>"
                "identificador" => "aff0070"
              ]
            ]
          ]
          14 => array:3 [
            "nombre" => "Paula"
            "apellidos" => "Ram&#237;rez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">o</span>"
                "identificador" => "aff0075"
              ]
            ]
          ]
          15 => array:3 [
            "nombre" => "Miguel"
            "apellidos" => "Salavert"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">p</span>"
                "identificador" => "aff0080"
              ]
            ]
          ]
          16 => array:3 [
            "nombre" => "Miguel"
            "apellidos" => "S&#225;nchez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">q</span>"
                "identificador" => "aff0085"
              ]
            ]
          ]
          17 => array:3 [
            "nombre" => "Jordi"
            "apellidos" => "Vall&#233;s"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">r</span>"
                "identificador" => "aff0090"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:18 [
          0 => array:3 [
            "entidad" => "Servicio de Microbiolog&#237;a&#44; Hospital Universitario 12 de Octubre&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "a"
            "identificador" => "aff1"
          ]
          1 => array:3 [
            "entidad" => "Unidad Cl&#237;nica de Cuidados Intensivos&#44; Hospital Universitario Virgen Macarena&#44; Sevilla&#44; Espa&#241;a"
            "etiqueta" => "b"
            "identificador" => "aff0005"
          ]
          2 => array:3 [
            "entidad" => "&#193;rea de Enfermedades Infecciosas&#44; Servicio de Microbiolog&#237;a&#44; Cl&#237;nica Universidad de Navarra&#44; Pamplona&#44; Espa&#241;a"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "Servicio de Microbiolog&#237;a Cl&#237;nica y Enfermedades Infecciosas&#44; Hospital General Universitario Gregorio Mara&#241;&#243;n&#44; Madrid&#59; Instituto de Investigaci&#243;n Sanitaria Gregorio Mara&#241;&#243;n&#44; Madrid&#59; CIBER de Enfermedades Respiratorias&#44; CibeRes&#44; Instituto de Salud Carlos III&#44; Madrid&#59; Departamento de Medicina&#44; Facultad de Medicina&#44; Universidad Complutense de Madrid&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
          4 => array:3 [
            "entidad" => "Servicio de Medicina Interna&#44; Hospital de Matar&#243;&#44; Matar&#243;&#44; Barcelona&#44; Espa&#241;a"
            "etiqueta" => "e"
            "identificador" => "aff0025"
          ]
          5 => array:3 [
            "entidad" => "Unidad de Enfermedades Infecciosas y Microbiolog&#237;a&#44; Hospital Universitario Virgen Macarena&#44; Sevilla&#44; Espa&#241;a"
            "etiqueta" => "f"
            "identificador" => "aff0030"
          ]
          6 => array:3 [
            "entidad" => "Servicio de Microbiolog&#237;a&#44; Hospital Universitari de Bellvitge&#44; IDIBELL&#44; L&#8217;Hospitalet de Llobregat&#44; Barcelona&#44; Espa&#241;a"
            "etiqueta" => "g"
            "identificador" => "aff0035"
          ]
          7 => array:3 [
            "entidad" => "Departamento de Microbiolog&#237;a Cl&#237;nica&#44; Fundaci&#243;n Jim&#233;nez D&#237;az&#44; Universidad Aut&#243;noma de Madrid&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "h"
            "identificador" => "aff0040"
          ]
          8 => array:3 [
            "entidad" => "Servei de Malalties Infeccioses&#44; Hospital Universitari Vall d&#8217;Hebron&#44; Universitat Aut&#242;noma de Barcelona&#44; Barcelona&#44; Espa&#241;a"
            "etiqueta" => "i"
            "identificador" => "aff0045"
          ]
          9 => array:3 [
            "entidad" => "Servicio de Enfermedades Infecciosas&#44; Hospital Universitario Marqu&#233;s de Valdecilla&#44; Santander&#44; Espa&#241;a"
            "etiqueta" => "j"
            "identificador" => "aff0050"
          ]
          10 => array:3 [
            "entidad" => "Unidad de Enfermedades Infecciosas&#44; Hospital Universitario Ram&#243;n y Cajal&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "k"
            "identificador" => "aff0055"
          ]
          11 => array:3 [
            "entidad" => "Unidad de Enfermedades Infecciosas y Microbiolog&#237;a Cl&#237;nica&#44; Hospital General Universitario Gregorio Mara&#241;&#243;n&#44; Instituto de Investigaci&#243;n Sanitaria Gregorio Mara&#241;&#243;n&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "l"
            "identificador" => "aff0060"
          ]
          12 => array:3 [
            "entidad" => "Unidad de Cuidados Intensivos&#44; Hospital Universitario de Canarias&#44; Santa Cruz de Tenerife&#44; Espa&#241;a"
            "etiqueta" => "m"
            "identificador" => "aff0065"
          ]
          13 => array:3 [
            "entidad" => "Unidad de Enfermedades Infecciosas&#44; Hospital Cl&#237;nico Universitario Lozano Blesa&#44; Instituto de Investigaci&#243;n Sanitaria Arag&#243;n &#40;IIS Arag&#243;n&#41;&#44; Zaragoza&#44; Espa&#241;a"
            "etiqueta" => "n"
            "identificador" => "aff0070"
          ]
          14 => array:3 [
            "entidad" => "Unidad de Cuidados Intensivos&#44; Hospital Universitari i Polit&#232;cnic La Fe&#44; Valencia&#59; CIBER de Enfermedades Respiratorias &#40;CibeRes&#41;&#44; Instituto de Salud Carlos III&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "o"
            "identificador" => "aff0075"
          ]
          15 => array:3 [
            "entidad" => "Unidad de Enfermedades Infecciosas&#44; Hospital Universitari i Polit&#232;cnic La Fe&#44; Valencia&#44; Espa&#241;a"
            "etiqueta" => "p"
            "identificador" => "aff0080"
          ]
          16 => array:3 [
            "entidad" => "Servicio de Medicina Intensiva&#44; Hospital Cl&#237;nico San Carlos&#44; Departamento de Medicina&#44; Facultad de Medicina&#44; Universidad Complutense de Madrid&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "q"
            "identificador" => "aff0085"
          ]
          17 => array:3 [
            "entidad" => "Unidad de Cuidados Intensivos&#44; Hospital Universitari Parc Taul&#237;&#44; Sabadell&#44; Barcelona&#59; CIBER de Enfermedades Respiratorias&#44; Instituto de Salud Carlos III&#44; Madrid&#44; Espa&#241;a"
            "etiqueta" => "r"
            "identificador" => "aff0090"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Resumen ejecutivo del documento de consenso sobre diagn&#243;stico y tratamiento de la bacteriemia relacionada con cat&#233;ter&#58; Gu&#237;a de Pr&#225;ctica Cl&#237;nica de la Sociedad Espa&#241;ola de Enfermedades Infecciosas &#40;SEIMC&#41; y de la Sociedad Espa&#241;ola de Medicina Intensiva Cr&#237;tica y Unidades Coronarias &#40;SEMICYUC&#41;"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction&#58; justification and aims</span><p id="par0005" class="elsevierStylePara elsevierViewall">Intravascular devices have become an essential component of modern medicine for the administration of intravenous fluids&#44; medication&#44; blood products and parenteral nutrition and for monitoring hemodynamic status and providing hemodialysis&#46; According to national data supplied by the study of the prevalence of nosocomial infections in Spain &#40;EPINE&#41;&#44; it is estimated that about 70&#37; of patients admitted to Spanish hospitals will wear one of these devices at some point during their stay&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">1</span></a> Local or systemic infections represent one of the main associated complications&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">2</span></a> The incidence of catheter-related infections varies considerably depending on the type and intended use&#44; the insertion site&#44; the experience and training of the individual who places the catheter&#44; the frequency with which the catheter is accessed&#44; duration of catheter placement&#44; the characteristics of the patient&#44; and the use of proven prevention strategies&#46; Catheter-related bloodstream infections &#40;CRBSIs&#41; are among the most frequent infections acquired in hospital&#46; Current estimates are that between 15 and 30&#37; of all nosocomial bacteremias are catheter-related&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">3</span></a> CRBSIs have significant associated morbidity&#44; incur increased hospital costs&#44;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">4</span></a> estimated at approximately 18&#44;000 euros per episode&#44; and length of stay&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">5</span></a> Attributable mortality ranges between 12 and 25&#37;&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">6</span></a> In recent years&#44; there has been a remarkable increase in our knowledge of the epidemiology of CRBSI and of the most appropriate methodologies for diagnosis&#44; management and prevention&#46; The vast amount of information accumulated and the inherent complexity of this type of infection make it necessary to sort and analyze the available information&#46; At the same time&#44; there are few current guidelines available on this topic&#46; The last Spanish catheter-related infections guidelines were published in 2004&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">7</span></a> The aim of this new guide is to update recommendations for the diagnosis and management of catheter-related bloodstream infections&#46; This document targets only microbiological diagnosis and antimicrobial therapy&#59; other aspects of infection management and prevention are therefore excluded&#46; Only adult patients with these infections are covered&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Methods</span><p id="par0010" class="elsevierStylePara elsevierViewall">The two participating Societies &#40;Sociedad Espa&#241;ola de Enfermedades Infecciosas y Microbiolog&#237;a Cl&#237;nica and the Sociedad Espa&#241;ola de Medicina Intensiva&#44; Cr&#237;tica y Unidades Coronarias&#41; nominated three coordinators for this project &#40;FC&#44; JGM and JLdP&#58; a microbiologist&#44; an intensivist&#44; and an infectious disease physician&#41;&#46; This coordinating group selected the rest of the members of the panel&#44; including microbiologists&#44; intensivists&#44; and infectious disease physicians&#46; The Scientific Committees of both Societies approved their proposal&#46; The present Statement was written following the SEIMC guidelines for consensus statements &#40;<a href="http://www.seimc.org/">www&#46;seimc&#46;org</a>&#41; as well as the recommendations of the AGREE Collaboration &#40;<a href="http://www.agreecollaboration.org/">www&#46;agreecollaboration&#46;org</a>&#41; for evaluating the methodological quality of clinical practice guidelines&#46; The strength of the recommendations and quality of the evidence were graded in accordance with ESCMID guidelines &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">The coordinating group identified 39 key topics that were formulated in accordance with the PICO format defining the population&#44; intervention&#44; comparator&#44; and outcome of interest&#46; These key questions were approved by the Scientific Committees of both Societies and then distributed to the different members of the panel &#40;2 or 3 questions each&#41; for further development&#46; The coordinating group wrote the first draft based on the sections submitted by each participant&#44; which was then sent to the panel for critical review&#46; Before its final approval&#44; the document was published on the intranet of both Societies and left open to suggestions and comments from members&#46; All authors and coordinators of the Statement have agreed the contents of the document and the final recommendations&#46;</p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">General aspects</span><p id="par0020" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">When should catheter-related bloodstream infection be suspected&#63;</span></p><p id="par0025" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">&#8226;</span><p id="par0030" class="elsevierStylePara elsevierViewall">CRBSI should be suspected in patients with intravenous catheters and fever&#44; chills or other signs of sepsis&#44; even in the absence of local signs of infection&#44; and especially if no alternative source is identified &#40;A-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">&#8226;</span><p id="par0035" class="elsevierStylePara elsevierViewall">Clinical suspicion of CRBSI should also increase in patients with intravenous catheters who have metastatic infections caused by hematogenous spread of microorganisms &#40;i&#46;e&#46; septic emboli&#41; &#40;A-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">&#8226;</span><p id="par0040" class="elsevierStylePara elsevierViewall">Persistent or recurrent bacteremia caused by microorganisms that tend to colonize or infect the skin in patients with intravenous catheters should lead to suspicion of CRBSI &#40;A-III&#41;&#46;</p></li></ul></p><p id="par0045" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">How is a complicated catheter-related bloodstream infection defined&#63;</span></p><p id="par0050" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">&#8226;</span><p id="par0055" class="elsevierStylePara elsevierViewall">Patients with CRBSI with endocarditis&#44; suppurative thrombophlebitis&#44; septic metastasis&#44; extraluminal infections&#44; septic shock&#44; non-resolving CRBSI&#44; and immunocompromised patients should be categorized as complicated CRBSI &#40;A-III&#41;&#46;</p></li></ul></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Diagnosis without catheter withdrawal &#40;conservative diagnosis&#41;</span><p id="par0060" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">How should blood cultures be taken&#63;</span></p><p id="par0065" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0015"><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">&#8226;</span><p id="par0070" class="elsevierStylePara elsevierViewall">Obtain blood cultures using an aseptic technique before the initiation of antimicrobial therapy &#40;A-I&#41;</p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">&#8226;</span><p id="par0075" class="elsevierStylePara elsevierViewall">Skin preparation for obtaining blood samples drawn percutaneously should be performed with proper techniques&#44; including the time to perform the procedure and leaving adequate time for the disinfectant to take effect &#40;A-I&#41;&#46; Alcohol-containing products are associated with low rates of contamination&#46; Alcohol-chlorhexidine solutions reduce blood culture contamination more efficiently than aqueous povidone-iodine &#40;A-I&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">&#8226;</span><p id="par0080" class="elsevierStylePara elsevierViewall">In patients with suspected CRBSI&#44; two pairs of blood cultures should be drawn&#44; one from a peripheral vein and the other from the catheter &#40;A-I&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">&#8226;</span><p id="par0085" class="elsevierStylePara elsevierViewall">For multiple-lumen venous catheters&#44; samples for blood culture should be obtained from all lumens &#40;A-II&#41;&#46;</p></li></ul></p><p id="par0090" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">How should conventional blood cultures be interpreted&#63;</span></p><p id="par0095" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0020"><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">&#8226;</span><p id="par0100" class="elsevierStylePara elsevierViewall">For diagnosis of CRBSI&#44; positivity of blood cultures obtained through the catheter &#8805;120<span class="elsevierStyleHsp" style=""></span>min before those from a peripheral vein with the same microorganism is highly suggestive&#46; An optimal DTP cut-off for the diagnosis of catheter-related candidemia has not been established&#46; &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel">&#8226;</span><p id="par0105" class="elsevierStylePara elsevierViewall">The interpretation of DTP should consider adherence to the procedural technique used and the type of microorganism &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0055"><span class="elsevierStyleLabel">&#8226;</span><p id="par0110" class="elsevierStylePara elsevierViewall">Rapid microbial identification by MALDI-TOF MS from a positive blood culture significantly reduces time to identification of microorganisms and has clinical impact on the management of patients with suspected bloodstream infection &#40;A-II&#41;&#46;</p></li></ul></p><p id="par0115" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">How should quantitative blood cultures be taken and interpreted&#63;</span></p><p id="par0120" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0025"><li class="elsevierStyleListItem" id="lsti0060"><span class="elsevierStyleLabel">&#8226;</span><p id="par0125" class="elsevierStylePara elsevierViewall">A quantitative blood culture with a colony count 3 times greater in a sample drawn through a catheter than from the peripheral vein supports a diagnosis of CRBSI &#40;A-II&#41;&#46; This method is less practicable for routine use&#46;</p></li></ul></p><p id="par0130" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What particular aspects should be considered for the diagnosis of CRBSI in patients on hemodialysis&#63;</span></p><p id="par0135" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0030"><li class="elsevierStyleListItem" id="lsti0065"><span class="elsevierStyleLabel">&#8226;</span><p id="par0140" class="elsevierStylePara elsevierViewall">Whenever possible&#44; paired blood samples from the CVC and a peripheral vein should be obtained for a CRBSI diagnosis in hemodialysis patients &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0070"><span class="elsevierStyleLabel">&#8226;</span><p id="par0145" class="elsevierStylePara elsevierViewall">Peripheral blood samples should be obtained from veins that are not intended for future creation of dialysis fistulae or grafts&#46; The veins of the hand for outpatients and hand or femoral veins for hospital inpatients should be used to obtain peripheral blood cultures &#40;A-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0075"><span class="elsevierStyleLabel">&#8226;</span><p id="par0150" class="elsevierStylePara elsevierViewall">If a blood sample cannot be drawn from a peripheral vein&#44; two separate samples should be drawn&#44; 10&#8211;15<span class="elsevierStyleHsp" style=""></span>min apart&#44; through the CVC or the dialysis circuit connected to the catheter &#40;B-II&#41;&#46;</p></li></ul></p><p id="par0155" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What is the present value of molecular techniques for the diagnosis of CRBSI&#63;</span></p><p id="par0160" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0035"><li class="elsevierStyleListItem" id="lsti0080"><span class="elsevierStyleLabel">&#8226;</span><p id="par0165" class="elsevierStylePara elsevierViewall">At the present time&#44; there is not enough information to recommend implementing these techniques in clinical practice for CRBSI diagnosis &#40;C-II&#41;&#46;</p></li></ul></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Diagnosis of CRBI with catheter withdrawal</span><p id="par0170" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">When should a catheter tip be sent for culture&#63;</span></p><p id="par0175" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0040"><li class="elsevierStyleListItem" id="lsti0085"><span class="elsevierStyleLabel">&#8226;</span><p id="par0180" class="elsevierStylePara elsevierViewall">Catheter cultures should only be obtained when catheter-related bloodstream infection is suspected &#40;A II&#41;&#46;</p></li></ul></p><p id="par0185" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">How should a catheter be sent and processed in the Microbiology Laboratory&#63;</span></p><p id="par0190" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0045"><li class="elsevierStyleListItem" id="lsti0090"><span class="elsevierStyleLabel"><span class="elsevierStyleBold">&#8226;</span></span><p id="par0195" class="elsevierStylePara elsevierViewall">The most reliable diagnostic methodologies are the semiquantitative &#40;roll plate&#41; or quantitative &#40;vortex or sonication methods&#41; catheter culture techniques &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0095"><span class="elsevierStyleLabel"><span class="elsevierStyleBold">&#8226;</span></span><p id="par0200" class="elsevierStylePara elsevierViewall">Qualitative cultures &#40;culture of the catheter tip by broth immersion&#41; are unreliable for distinguishing between contamination and infection and are not therefore suitable for the diagnosis of CRBSI &#40;A-II&#41;&#46;</p></li></ul></p><p id="par0205" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">How should the results of catheter cultures be interpreted&#63;</span></p><p id="par0210" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0050"><li class="elsevierStyleListItem" id="lsti0100"><span class="elsevierStyleLabel">&#8226;</span><p id="par0215" class="elsevierStylePara elsevierViewall">The presence of 15 CFU per plate or more by semiquantitative culture &#40;roll-plate&#41; is indicative of significant catheter colonization &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0105"><span class="elsevierStyleLabel">&#8226;</span><p id="par0220" class="elsevierStylePara elsevierViewall">For quantitative culture methods based on vortexing or flushing the internal surface&#44; a count of 10<span class="elsevierStyleSup">3</span><span class="elsevierStyleHsp" style=""></span>CFU&#47;segment or more reflects significant catheter colonization &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0110"><span class="elsevierStyleLabel">&#8226;</span><p id="par0225" class="elsevierStylePara elsevierViewall">For quantitative culture methods based on sonication&#44; counts above 10<span class="elsevierStyleSup">2</span> CFU&#47;segment indicate significant catheter colonization &#40;A-II&#41;&#46;</p></li></ul></p><p id="par0230" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">How should a subcutaneous reservoir be processed&#63;</span></p><p id="par0235" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0055"><li class="elsevierStyleListItem" id="lsti0115"><span class="elsevierStyleLabel">&#8226;</span><p id="par0240" class="elsevierStylePara elsevierViewall">Venous access devices removed for suspected CRBSI should be sent to the microbiology laboratory&#46; Routine processing should include a combination of cultures from different parts of the VAD&#44; including a culture after septum sonication and semiquantitative catheter tip cultures &#40;B-II&#41;&#46;</p></li></ul></p><p id="par0245" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What other conservative techniques may be used for diagnosis of CRBSI&#63;</span></p><p id="par0250" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0060"><li class="elsevierStyleListItem" id="lsti0120"><span class="elsevierStyleLabel">&#8226;</span><p id="par0255" class="elsevierStylePara elsevierViewall">Endoluminal brushing of the internal surface of the catheter may be useful for diagnosis of CRBSI&#46; However&#44; the procedure is impractical and major side-effects have been reported &#40;C-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0125"><span class="elsevierStyleLabel">&#8226;</span><p id="par0260" class="elsevierStylePara elsevierViewall">Semiquantitative cultures of skin around the catheter insertion site and catheter hubs with &#8805;15<span class="elsevierStyleHsp" style=""></span>cfu may be indicative for CRBSI&#46; These procedures must be combined with peripheral blood culture &#40;B-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0130"><span class="elsevierStyleLabel">&#8226;</span><p id="par0265" class="elsevierStylePara elsevierViewall">Gram stain &#8211; acridine orange leukocyte cytospin &#40;AOLC&#41; of catheter blood may be used as a rapid method for diagnosis of CRBSI&#46; The presence of any microorganisms in a minimum of 100 high-powered fields may be indicative of CRBSI &#40;B-II&#41;&#46;</p></li></ul></p><p id="par0270" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What is the value of molecular techniques for the diagnosis of CRBSI after catheter removal&#63;</span></p><p id="par0275" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0065"><li class="elsevierStyleListItem" id="lsti0135"><span class="elsevierStyleLabel">&#8226;</span><p id="par0280" class="elsevierStylePara elsevierViewall">16S rRNA PCR could be performed with septum sonication fluid to rule out or confirm VAD-RBSI in patients undergoing antibiotic therapy &#40;C-III&#41;&#46;</p></li></ul></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Diagnosis of local signs of infection</span><p id="par0285" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What samples should be taken and how should they be interpreted when an insertion site infection is suspected&#63;</span></p><p id="par0290" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0070"><li class="elsevierStyleListItem" id="lsti0140"><span class="elsevierStyleLabel">&#8226;</span><p id="par0295" class="elsevierStylePara elsevierViewall">When catheter infection is suspected and there is exudate at the catheter insertion site&#44; it should be sent for Gram staining and culture&#46; Blood cultures should also be drawn &#40;A-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0145"><span class="elsevierStyleLabel">&#8226;</span><p id="par0300" class="elsevierStylePara elsevierViewall">In patients with suspected catheter-related infection but negative superficial cultures &#40;growth of &#60;15<span class="elsevierStyleHsp" style=""></span>CFU from both the insertion site and catheter hub cultures&#41;&#44; the possibility of infection can reasonably be ruled out &#40;B-II&#41;&#46;</p></li></ul></p></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Catheter related bloodstream infection treatment</span><p id="par0305" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">When can a catheter be retained until blood cultures are available&#63;</span></p><p id="par0310" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0075"><li class="elsevierStyleListItem" id="lsti0150"><span class="elsevierStyleLabel">&#8226;</span><p id="par0315" class="elsevierStylePara elsevierViewall">Immediate removal of the CVC is not routinely recommended when CRBSI is suspected in patients who are hemodynamically stable&#44; without autoimmune diseases or immunosuppressive therapy&#44; intravascular foreign bodies or organ transplants&#44; no suppuration at the insertion site or bacteremia&#47;fungemia &#40;A-I&#41;&#46;</p></li></ul></p><p id="par0320" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">When is it safe to perform a catheter exchange over a guidewire&#63;</span></p><p id="par0325" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0080"><li class="elsevierStyleListItem" id="lsti0155"><span class="elsevierStyleLabel"><span class="elsevierStyleBold">&#8226;</span></span><p id="par0330" class="elsevierStylePara elsevierViewall">Routine replacement of a CVC by guidewire exchange is not recommended because this strategy is associated with a higher risk of infectious complications&#46; &#40;B-II&#41;</p></li><li class="elsevierStyleListItem" id="lsti0160"><span class="elsevierStyleLabel">&#8226;</span><p id="par0335" class="elsevierStylePara elsevierViewall">Guidewire exchange of a CVC is contraindicated in patients with documented catheter infections&#46; &#40;A-II&#41;</p></li><li class="elsevierStyleListItem" id="lsti0165"><span class="elsevierStyleLabel"><span class="elsevierStyleBold">&#8226;</span></span><p id="par0340" class="elsevierStylePara elsevierViewall">Guidewire exchange should be restricted to patients with very difficult venous access &#40;i&#46;e&#46; extensive burns&#44; morbid obesity&#44; or severe coagulopathy&#41; and without documented catheter infection &#40;B-II&#41;&#46; In this case&#44; a meticulous aseptic technique and a culture of the catheter tip are mandatory&#46; &#40;A-III&#41;</p></li><li class="elsevierStyleListItem" id="lsti0170"><span class="elsevierStyleLabel"><span class="elsevierStyleBold">&#8226;</span></span><p id="par0345" class="elsevierStylePara elsevierViewall">If the catheter tip culture is positive&#44; the new line&#44; inserted over a guidewire&#44; should be re-placed via a new direct venipuncture&#46; &#40;C-III&#41;</p></li></ul></p><p id="par0350" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What should be done if the catheter tip culture is positive but the blood cultures are negative&#63;</span></p><p id="par0355" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0085"><li class="elsevierStyleListItem" id="lsti0175"><span class="elsevierStyleLabel">&#8226;</span><p id="par0360" class="elsevierStylePara elsevierViewall">Antibiotic treatment &#40;i&#46;e&#46; 5&#8211;7 days&#41; should be given to patients with catheter tip cultures positive for <span class="elsevierStyleItalic">S&#46; aureus</span> and negative blood cultures if the patient shows systemic signs of infection or signs of local infection &#40;B-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0180"><span class="elsevierStyleLabel">&#8226;</span><p id="par0365" class="elsevierStylePara elsevierViewall">In non-neutropenic patients or those without valvular heart disease&#44; the presence of a catheter tip culture positive for <span class="elsevierStyleItalic">Candida</span> spp&#46; and negative or unavailable blood cultures should be assessed on an individual basis before starting systematic antifungal treatment&#46; Antifungal treatment should not be prescribed for patients without systemic signs of infection &#40;B-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0185"><span class="elsevierStyleLabel">&#8226;</span><p id="par0370" class="elsevierStylePara elsevierViewall">No clear recommendations can be given for catheters colonized with other microorganisms &#40;C-III&#41;&#46;</p></li></ul></p><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Empirical antimicrobial therapy</span><p id="par0375" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What is the empirical antimicrobial therapy for CRBSI&#63;</span></p><p id="par0380" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0090"><li class="elsevierStyleListItem" id="lsti0190"><span class="elsevierStyleLabel">&#8226;</span><p id="par0385" class="elsevierStylePara elsevierViewall">If CRBSI is suspected&#44; antimicrobial therapy should be started as soon as possible with a bactericidal agent active against S&#46; aureus and CoNS&#44; especially if associated with sepsis or septic shock &#40;B-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0195"><span class="elsevierStyleLabel">&#8226;</span><p id="par0390" class="elsevierStylePara elsevierViewall">Vancomycin is recommended for empirical therapy in patients with suspected CRBSI &#40;B-II&#41;&#46; Teicoplanin is not recommended as empirical therapy&#44; given the existence of coagulase-negative staphylococci with reduced susceptibility to teicoplanin &#40;C-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0200"><span class="elsevierStyleLabel">&#8226;</span><p id="par0395" class="elsevierStylePara elsevierViewall">Daptomycin can be administered for cases of CRBSI with septic shock &#40;C-III&#41;&#44; acute kidney injury &#40;B-III&#41;&#44; to patients with recent exposure to vancomycin &#40;&#62;1 week in the past 3 months&#41; &#40;C-III&#41; or if the local prevalence of S&#46; aureus isolates with vancomycin MIC<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>2&#46;0<span class="elsevierStyleHsp" style=""></span>&#956;g&#47;ml is high &#40;C-III&#41;&#46; The local prevalence of S&#46; aureus isolates with vancomycin MIC<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>1&#46;5<span class="elsevierStyleHsp" style=""></span>&#956;g&#47;ml supporting routine empirical use of daptomycin remains undefined&#46;</p></li><li class="elsevierStyleListItem" id="lsti0205"><span class="elsevierStyleLabel">&#8226;</span><p id="par0400" class="elsevierStylePara elsevierViewall">Linezolid should only be used in patients with contraindications for the previous agents &#40;B-II&#41;&#46;</p></li></ul></p><p id="par0405" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">When should empirical coverage of Gram-negative bacilli or fungi be added&#63;</span></p><p id="par0410" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0095"><li class="elsevierStyleListItem" id="lsti0210"><span class="elsevierStyleLabel">&#8226;</span><p id="par0415" class="elsevierStylePara elsevierViewall">Patients with suspected CRBSI should receive empirical antibiotic therapy &#40;in addition to coverage for Gram-positive pathogens&#41; to cover Gram-negative bacilli under any of the following circumstances&#58; hemodynamic instability &#40;septic shock&#41;&#44; neutropenia or hematologic malignancy&#44; solid organ or bone marrow transplant&#44; femoral catheter in place&#44; a high index of colonization with Gram-negative bacilli or prolonged ICU admission &#40;C-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0215"><span class="elsevierStyleLabel">&#8226;</span><p id="par0420" class="elsevierStylePara elsevierViewall">Antimicrobial therapy should be adapted to local epidemiology and must include an antipseudomonal agent &#40;piperacillin-tazobactam&#44; carbapenems&#44; a fourth-generation cephalosporin&#44; aztreonam&#44; quinolones or aminoglycosides&#41; &#40;A-II&#41;&#46; Aztreonam and cephalosporins should be avoided in patients with colonization or at risk for extended-spectrum &#946;-lactamase infections &#40;A-I&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0220"><span class="elsevierStyleLabel">&#8226;</span><p id="par0425" class="elsevierStylePara elsevierViewall">The need for empirical antifungal therapy in a patient with suspected catheter-related candidemia should be evaluated along with the possibility of catheter removal &#40;A-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0225"><span class="elsevierStyleLabel">&#8226;</span><p id="par0430" class="elsevierStylePara elsevierViewall">Empirical therapy for suspected catheter-related candidemia should be considered in patients who are hemodynamically unstable with one or more of the following conditions&#58; total parenteral nutrition&#44; prolonged use of broad-spectrum antibiotics&#44; malignancy&#44; femoral catheterization&#44; colonization due to Candida species at multiple sites or intense previous anti-anaerobic therapy &#40;C-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0230"><span class="elsevierStyleLabel">&#8226;</span><p id="par0435" class="elsevierStylePara elsevierViewall">The use of biomarkers &#40;such as 1&#44;3-beta-D-glucan&#41; may be useful when considering initiation of empirical treatment &#40;B-III&#41;&#46;</p></li></ul></p><p id="par0440" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What particular aspects should be considered in the empirical treatment of CRBSI in patients on hemodialysis&#63;</span></p><p id="par0445" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0100"><li class="elsevierStyleListItem" id="lsti0235"><span class="elsevierStyleLabel">&#8226;</span><p id="par0450" class="elsevierStylePara elsevierViewall">Conservative management of CRBSI should be attempted with hemodialysis patients&#46; Combining systemic and local intracatheter antibiotics is associated with improved results compared to systemic antibiotics alone &#40;A-I&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0240"><span class="elsevierStyleLabel">&#8226;</span><p id="par0455" class="elsevierStylePara elsevierViewall">In patients with a tunneled hemodialysis catheter&#44; guidewire exchange is an alternative&#44; especially when catheter removal is not feasible &#40;C-III&#41;&#46;</p></li></ul></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Targeted antimicrobial therapy</span><p id="par0460" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What is the recommended directed therapy and optimal duration of treatment for CRBSI due to</span><span class="elsevierStyleItalic"><span class="elsevierStyleBold">Staphylococcus aureus</span></span><span class="elsevierStyleBold">&#63;</span></p><p id="par0465" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0105"><li class="elsevierStyleListItem" id="lsti0245"><span class="elsevierStyleLabel">&#8226;</span><p id="par0470" class="elsevierStylePara elsevierViewall">The treatment of choice for an episode of MSSA CRBSI is cloxacillin or cefazoline &#40;B-I&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0250"><span class="elsevierStyleLabel">&#8226;</span><p id="par0475" class="elsevierStylePara elsevierViewall">Patients allergic to beta-lactams should be treated with daptomycin &#40;A-I&#41; or a glycopeptide &#40;B-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0255"><span class="elsevierStyleLabel">&#8226;</span><p id="par0480" class="elsevierStylePara elsevierViewall">The best antimicrobial treatment for episodes caused by MSSA strains with reduced susceptibility to vancomycin &#40;MIC<span class="elsevierStyleHsp" style=""></span>&#8805;<span class="elsevierStyleHsp" style=""></span>1&#46;5<span class="elsevierStyleHsp" style=""></span>mg&#47;L measured by E-test&#41; has not been elucidated&#46; This panel suggests using a combination of cloxacillin and daptomycin when blood cultures remain positive and&#47;or there is no obvious clinical improvement after catheter removal &#40;C-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0260"><span class="elsevierStyleLabel">&#8226;</span><p id="par0485" class="elsevierStylePara elsevierViewall">Vancomycin is the treatment of choice for CRBSI caused by MRSA &#40;B-II&#41;&#46; Teicoplanin may be a valid alternative&#44; especially in cases of serious side effects associated with the use of vancomycin&#46; &#40;C-III&#41;</p></li><li class="elsevierStyleListItem" id="lsti0265"><span class="elsevierStyleLabel">&#8226;</span><p id="par0490" class="elsevierStylePara elsevierViewall">Alternatively&#44; patients may be treated with daptomycin&#44; specifically if the MIC measured by E-test is &#8805;1&#46;5<span class="elsevierStyleHsp" style=""></span>mg&#47;L &#40;A-I&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0270"><span class="elsevierStyleLabel">&#8226;</span><p id="par0495" class="elsevierStylePara elsevierViewall">Linezolid should only be used in patients when the previous agents are contraindicated &#40;C-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0275"><span class="elsevierStyleLabel">&#8226;</span><p id="par0500" class="elsevierStylePara elsevierViewall">In both MSSA and MRSA CRBSI&#44; blood cultures should be obtained after 72<span class="elsevierStyleHsp" style=""></span>h of antibiotic therapy &#40;C-III&#41;&#46;</p></li></ul></p><p id="par0505" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What is the recommended directed therapy and optimal duration of treatment for CRBSI due to coagulase-negative Staphylococcus &#40;CoNS&#41;&#63;</span></p><p id="par0510" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0110"><li class="elsevierStyleListItem" id="lsti0280"><span class="elsevierStyleLabel">&#8226;</span><p id="par0515" class="elsevierStylePara elsevierViewall">Cloxacillin or cefazolin are the treatments of choice for episodes of CRBSI caused by CoNS susceptible to methicillin &#40;B-I&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0285"><span class="elsevierStyleLabel">&#8226;</span><p id="par0520" class="elsevierStylePara elsevierViewall">For CoNS resistant to methicillin&#44; a glycopeptide is the treatment of choice for directed therapy &#40;B-II&#41;&#46; Teicoplanin is recommended in the case of serious side effects associated with vancomycin&#46; &#40;C-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0290"><span class="elsevierStyleLabel">&#8226;</span><p id="par0525" class="elsevierStylePara elsevierViewall">The optimal trough concentration of vancomycin for the treatment of CoNS CRBSI is an unresolved issue and this panel cannot issue a specific recommendation &#40;C-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0295"><span class="elsevierStyleLabel">&#8226;</span><p id="par0530" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">S&#46; lugdunensis</span> CRBSI should be managed as for S aureus CRBSI &#40;C-III&#41;&#46;</p></li></ul></p><p id="par0535" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What is the recommended directed therapy and its optimal duration for CRBSI due to</span><span class="elsevierStyleItalic"><span class="elsevierStyleBold">Enterococcus</span></span><span class="elsevierStyleBold">spp&#46;&#63;</span></p><p id="par0540" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0115"><li class="elsevierStyleListItem" id="lsti0300"><span class="elsevierStyleLabel">&#8226;</span><p id="par0545" class="elsevierStylePara elsevierViewall">Enterococcal CRBSI should be treated with catheter withdrawal and one active antimicrobial &#40;A-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0305"><span class="elsevierStyleLabel">&#8226;</span><p id="par0550" class="elsevierStylePara elsevierViewall">Ampicillin is the drug of choice for susceptible isolates &#40;A-II&#41;&#46; Vancomycin should be reserved for isolates resistant to ampicillin or cases of beta-lactam allergy&#46; For vancomycin-resistant isolates or severe adverse effects&#44; linezolid is preferred to daptomycin &#40;B-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0310"><span class="elsevierStyleLabel">&#8226;</span><p id="par0555" class="elsevierStylePara elsevierViewall">There is no evidence that combination therapy is necessary if IE has been properly ruled out &#40;A-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0315"><span class="elsevierStyleLabel">&#8226;</span><p id="par0560" class="elsevierStylePara elsevierViewall">Despite data suggesting that duration of treatment may be shorter&#44; the standard 7&#8211;14 day regimen continues to be recommended &#40;A-III&#41;&#46;</p></li></ul></p><p id="par0565" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What is the recommended directed therapy and its optimal duration for CRBSI due to Gram-negative bacilli&#63;</span></p><p id="par0570" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0120"><li class="elsevierStyleListItem" id="lsti0320"><span class="elsevierStyleLabel">&#8226;</span><p id="par0575" class="elsevierStylePara elsevierViewall">Directed therapy for GN-CRBSI should be chosen on the basis of the susceptibility results &#40;C-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0325"><span class="elsevierStyleLabel"><span class="elsevierStyleBold">&#8226;</span></span><p id="par0580" class="elsevierStylePara elsevierViewall">The appropriate length of antimicrobial therapy has not been elucidated&#44; although it is recommended to continue therapy for at least 7 days &#40;C-II&#41;&#46;</p></li></ul></p><p id="par0585" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What is the recommended directed therapy and its optimal duration for CRBSI due to</span><span class="elsevierStyleItalic"><span class="elsevierStyleBold">Candida</span></span><span class="elsevierStyleBold">spp&#46;&#63;</span></p><p id="par0590" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0125"><li class="elsevierStyleListItem" id="lsti0330"><span class="elsevierStyleLabel">&#8226;</span><p id="par0595" class="elsevierStylePara elsevierViewall">In patients with <span class="elsevierStyleItalic">Candida</span> spp CRBSI&#44; this panel advocates de-escalation from an echinocandin or a lipid formulation of amphotericin B to fluconazole for susceptible isolates in clinically stable patients who have undergone catheter removal &#40;B-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0335"><span class="elsevierStyleLabel">&#8226;</span><p id="par0600" class="elsevierStylePara elsevierViewall">The recommended duration of therapy for candidemia without obvious metastatic complications is two weeks after the first set of negative blood cultures &#40;B-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0340"><span class="elsevierStyleLabel">&#8226;</span><p id="par0605" class="elsevierStylePara elsevierViewall">In candidemia&#44; all intravascular catheters should be removed if at all feasible &#40;B-II&#41;&#44; particularly in patients with septic shock and <span class="elsevierStyleItalic">Candida</span> CRBSI is suspected &#40;B-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0345"><span class="elsevierStyleLabel">&#8226;</span><p id="par0610" class="elsevierStylePara elsevierViewall">If a catheter that is the source of a Candida bloodstream infection cannot be removed for any reason and remains in place&#44; an antifungal agent with high activity against biofilms should be used &#40;i&#46;e&#46; an echinocandin or liposomal amphotericin B&#41; &#40;A-II&#41;&#46;</p></li></ul></p><p id="par0615" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What is the recommended directed therapy and its optimal duration for CRBSI due to nontuberculous mycobacteria &#40;NTM&#41;&#63;</span></p><p id="par0620" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0130"><li class="elsevierStyleListItem" id="lsti0350"><span class="elsevierStyleLabel">&#8226;</span><p id="par0625" class="elsevierStylePara elsevierViewall">The treatment for CRBSI caused by NTM involves removal of the infected catheter &#40;B-II&#41; followed by combination antimicrobial treatment appropriate for the species involved &#40;B-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0355"><span class="elsevierStyleLabel">&#8226;</span><p id="par0630" class="elsevierStylePara elsevierViewall">The duration of treatment for NTM CRBSI should be 6&#8211;12 weeks to prevent recurrence of infection and the development of septic metastases &#40;B-III&#41;&#46;</p></li></ul></p><p id="par0635" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Should antimicrobials for CRSBI be administered intravenously for the entire course of treatment&#63;</span></p><p id="par0640" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0135"><li class="elsevierStyleListItem" id="lsti0360"><span class="elsevierStyleLabel">&#8226;</span><p id="par0645" class="elsevierStylePara elsevierViewall">Sequential oral therapy can be considered in clinically stable patients without metastatic complications and with negative blood cultures after onset of treatment and removal of the intravenous line&#44; if a therapeutic option with high oral bioavailability is available &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0365"><span class="elsevierStyleLabel">&#8226;</span><p id="par0650" class="elsevierStylePara elsevierViewall">In uncomplicated CRBSI caused by fluoroquinolone-susceptible staphylococci&#44; initial intravenous antibiotic treatment may be switched to high-dose oral fluoroquinolones plus rifampicin in order to complete the course of antibiotic therapy if the patient is clinically stable and clearance of bacteremia is documented&#46; Linezolid could be an option if the microorganism involved is fluorquinolone-resistant &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0370"><span class="elsevierStyleLabel">&#8226;</span><p id="par0655" class="elsevierStylePara elsevierViewall">In uncomplicated CRBSI caused by fluoroquinolone-susceptible Gram-negative bacilli&#44; initial intravenous antibiotic treatment may be switched to high-dose oral fluoroquinolones in order to complete the course of antibiotic therapy if the patient is clinically stable and clearance of bacteremia is documented &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0375"><span class="elsevierStyleLabel">&#8226;</span><p id="par0660" class="elsevierStylePara elsevierViewall">A step-down from an echinocandin or lipid formulation of amphotericin B to oral fluconazole is safe and effective &#40;C-III&#41;&#46;</p></li></ul></p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Conservative treatment&#58; antibiotic lock therapy &#40;ALT&#41;</span><p id="par0665" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">When is conservative management with antibiotic lock therapy recommended&#63;</span></p><p id="par0670" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0140"><li class="elsevierStyleListItem" id="lsti0380"><span class="elsevierStyleLabel">&#8226;</span><p id="par0675" class="elsevierStylePara elsevierViewall">Conservative treatment should not be prescribed for patients with metastatic or local septic complications &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0385"><span class="elsevierStyleLabel">&#8226;</span><p id="par0680" class="elsevierStylePara elsevierViewall">The use of lock therapy added to systemic antimicrobial agents is systematically recommended for infected catheters that fulfill the criteria for catheter retention&#58; the patient is stable and the microorganism involved is considered to be of low virulence &#40;i&#46;e&#46; CoNS&#41; &#40;A-I&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0390"><span class="elsevierStyleLabel">&#8226;</span><p id="par0685" class="elsevierStylePara elsevierViewall">In stable patients without local or systemic complications&#44; conservative treatment may also be attempted for enterococci&#44; corynebacterium &#40;except Corynebacterium jeikeium&#41; and Gram-negatives &#40;consultation with an ID expert is suggested in such cases&#41; &#40;C-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0395"><span class="elsevierStyleLabel">&#8226;</span><p id="par0690" class="elsevierStylePara elsevierViewall">The use of an antibiotic lock does not preclude the need for systemic antimicrobial therapy &#40;A-I&#41;&#46;</p></li></ul></p><p id="par0695" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What antibiotics and concentrations of antibiotic lock solutions are recommended&#63;</span></p><p id="par0700" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0145"><li class="elsevierStyleListItem" id="lsti0400"><span class="elsevierStyleLabel"><span class="elsevierStyleBold">&#8226;</span></span><p id="par0705" class="elsevierStylePara elsevierViewall">The most frequently used antibiotics for conservative treatment of CRBSI using ALT are vancomycin 2000<span class="elsevierStyleHsp" style=""></span>mg&#47;L&#44; teicoplanin 10&#44;000<span class="elsevierStyleHsp" style=""></span>mg&#47;L&#44; daptomycin 5000<span class="elsevierStyleHsp" style=""></span>mg&#47;L&#44; ciprofloxacin 2000<span class="elsevierStyleHsp" style=""></span>mg&#47;L&#44; and amikacin 2000<span class="elsevierStyleHsp" style=""></span>mg&#47;L &#40;B-I&#41;&#46;</p></li></ul></p><p id="par0710" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">How should antibiotic lock therapy be performed&#63;</span></p><p id="par0715" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0150"><li class="elsevierStyleListItem" id="lsti0405"><span class="elsevierStyleLabel">&#8226;</span><p id="par0720" class="elsevierStylePara elsevierViewall">An ALT solution should be prepared under sterile conditions&#46; It should be infused after removing the previous dose and the exact volume of the catheter lumen should be infused&#46; The recommended duration of ALT is 10&#8211;14 days&#46; The ALT solution must remain in the catheter lumen for a minimum of 12<span class="elsevierStyleHsp" style=""></span>h a day and should be replaced every 24&#8211;72<span class="elsevierStyleHsp" style=""></span>h &#40;B-I&#41;&#46;</p></li></ul></p><p id="par0725" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What non-antibiotic substances could be used for lock therapy&#63;</span></p><p id="par0730" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0155"><li class="elsevierStyleListItem" id="lsti0410"><span class="elsevierStyleLabel">&#8226;</span><p id="par0735" class="elsevierStylePara elsevierViewall">70&#37; ethanol and taurolidine locks can also be used for the conservative treatment of CRBSI&#46; There is no evidence to advocate for their routine use &#40;B-I&#41;&#46;</p></li></ul></p><p id="par0740" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What are the criteria for failure of conservative management&#63;</span></p><p id="par0745" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0160"><li class="elsevierStyleListItem" id="lsti0415"><span class="elsevierStyleLabel">&#8226;</span><p id="par0750" class="elsevierStylePara elsevierViewall">Any clinical condition or catheter dysfunction prompting catheter removal should be considered failure of conservative management &#40;A-I&#41;&#46;</p></li></ul></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Management of local complications</span><p id="par0755" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">How should insertion site infection be managed&#63;</span></p><p id="par0760" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0165"><li class="elsevierStyleListItem" id="lsti0420"><span class="elsevierStyleLabel">&#8226;</span><p id="par0765" class="elsevierStylePara elsevierViewall">For peripheral venous catheters&#44; catheter removal is mandatory if there is local pain&#44; induration&#44; erythema or exudate &#40;A-I&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0425"><span class="elsevierStyleLabel">&#8226;</span><p id="par0770" class="elsevierStylePara elsevierViewall">For non-tunneled CVCs&#44; the presence of erythema or purulence at the catheter insertion site requires immediate catheter removal &#40;B-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0430"><span class="elsevierStyleLabel">&#8226;</span><p id="par0775" class="elsevierStylePara elsevierViewall">For uncomplicated exit site infections with long-term catheters&#44; a conservative approach with topical antimicrobial agents should first be attempted&#46; In cases of topical treatment failure&#44; systemic antibiotics should be administered &#40;B-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0435"><span class="elsevierStyleLabel">&#8226;</span><p id="par0780" class="elsevierStylePara elsevierViewall">Persistence of clinical signs of infection beyond 72<span class="elsevierStyleHsp" style=""></span>h of conservative management requires removal of the catheter &#40;B-II&#41;&#46;</p></li></ul></p><p id="par0785" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">How should tunnelitis be managed&#63;</span></p><p id="par0790" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0170"><li class="elsevierStyleListItem" id="lsti0440"><span class="elsevierStyleLabel">&#8226;</span><p id="par0795" class="elsevierStylePara elsevierViewall">Patients with tunnel infection not associated with a hemodialysis catheter require catheter removal&#44; incision and drainage&#44; if indicated&#44; and 7&#8211;10 days of systemic antimicrobial therapy in the absence of concomitant bacteremia or candidemia &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0445"><span class="elsevierStyleLabel">&#8226;</span><p id="par0800" class="elsevierStylePara elsevierViewall">For tunnelitis without fever in hemodialysis catheters&#44; systemic antibiotic therapy may be attempted first &#40;A-II&#41;&#46; In tunnel infection with fever&#44; catheter removal is the first therapeutic option together with systemic antimicrobial therapy &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0450"><span class="elsevierStyleLabel">&#8226;</span><p id="par0805" class="elsevierStylePara elsevierViewall">In tunnelitis&#44; conservative management is associated with higher failure rates &#40;B-II&#41;&#46;</p></li></ul></p><p id="par0810" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">How should a local infection associated with a port reservoir be managed&#63;</span></p><p id="par0815" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0175"><li class="elsevierStyleListItem" id="lsti0455"><span class="elsevierStyleLabel">&#8226;</span><p id="par0820" class="elsevierStylePara elsevierViewall">In the presence of signs of local inflammation at a port reservoir&#44; the port must be removed&#44; the affected tissue drained and systemic antibiotic therapy started &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0460"><span class="elsevierStyleLabel">&#8226;</span><p id="par0825" class="elsevierStylePara elsevierViewall">If a conservative strategy is the only option&#44; a combination of systemic antibiotics and antibiotic lock therapy should be prescribed&#44; bearing in mind that this approach is associated with a high failure rate &#40;B-II&#41;&#46;</p></li></ul></p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Patient follow-up</span><p id="par0830" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">In which patients and when should a follow-up blood culture be taken&#63;</span></p><p id="par0835" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0180"><li class="elsevierStyleListItem" id="lsti0465"><span class="elsevierStyleLabel">&#8226;</span><p id="par0840" class="elsevierStylePara elsevierViewall">Follow-up blood cultures should be taken from all patients with <span class="elsevierStyleItalic">S&#46; aureus</span> or <span class="elsevierStyleItalic">Candida</span> spp CRBSI &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0470"><span class="elsevierStyleLabel">&#8226;</span><p id="par0845" class="elsevierStylePara elsevierViewall">In patients with S&#46; aureus CRBSI&#44; we recommend that follow-up blood cultures should be obtained every 72<span class="elsevierStyleHsp" style=""></span>h until the first negative result &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0475"><span class="elsevierStyleLabel">&#8226;</span><p id="par0850" class="elsevierStylePara elsevierViewall">Control blood cultures in CRBSI due to <span class="elsevierStyleItalic">Candida</span> spp should be obtained every 48<span class="elsevierStyleHsp" style=""></span>h until the first negative blood culture &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0480"><span class="elsevierStyleLabel">&#8226;</span><p id="par0855" class="elsevierStylePara elsevierViewall">For other causative microorganisms of CRBSI and if catheter salvage is attempted&#44; follow-up blood cultures should be obtained 72<span class="elsevierStyleHsp" style=""></span>h after starting appropriate antibiotic therapy&#46; If persistent bacteremia is documented&#44; catheter removal is required &#40;B-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0485"><span class="elsevierStyleLabel">&#8226;</span><p id="par0860" class="elsevierStylePara elsevierViewall">It is not necessary to routinely perform follow-up blood cultures in patients with CRBSI due to microorganisms other than <span class="elsevierStyleItalic">S&#46; aureus</span> or <span class="elsevierStyleItalic">Candida</span> spp if the catheter has been withdrawn &#40;A-II&#41;&#46;</p></li></ul></p><p id="par0865" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">When should echocardiography be performed&#63;</span></p><p id="par0870" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendations&#58;</span><ul class="elsevierStyleList" id="lis0185"><li class="elsevierStyleListItem" id="lsti0490"><span class="elsevierStyleLabel">&#8226;</span><p id="par0875" class="elsevierStylePara elsevierViewall">TEE should be performed in the vast majority of patients with Staphylococcus aureus bacteremia&#46; TEE is not necessary or can be delayed in patients without the following risk factors&#58; prolonged bacteremia&#44; hemodialysis&#44; metastatic foci of infection&#44; IVDA&#44; implantable CVC&#44; intracardiac device&#44; prosthetic valve&#44; previous IE or cardiac structural abnormality &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0495"><span class="elsevierStyleLabel">&#8226;</span><p id="par0880" class="elsevierStylePara elsevierViewall">The need for TEE in episodes of CRBSI caused by other pathogens should be individualized&#46; This panel considers that IE should be ruled out in all patients with persistent bacteremia &#40;or fungemia&#41; &#40;C-III&#41;&#46; <span class="elsevierStyleItalic">Enterococcus</span> spp and <span class="elsevierStyleItalic">Candida</span> spp pathogens are associated with a high risk of developing endocarditis&#46;</p></li></ul></p><p id="par0885" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">What is the diagnosis and management for w&#63;</span></p><p id="par0890" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0190"><li class="elsevierStyleListItem" id="lsti0500"><span class="elsevierStyleLabel">&#8226;</span><p id="par0895" class="elsevierStylePara elsevierViewall">Suppurative thrombophlebitis should be ruled out in all episodes of CRBSI with persistent bacteremia &#40;A-II&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0505"><span class="elsevierStyleLabel">&#8226;</span><p id="par0900" class="elsevierStylePara elsevierViewall">Confirmed diagnosis&#44; mainly by ultrasonography&#44; should be followed by catheter withdrawal&#44; prolonged antibiotic treatment and an individualized assessment of the need for anticoagulation &#40;A-II&#41;&#46;</p></li></ul></p><p id="par0905" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">When can a new catheter be inserted&#63;</span></p><p id="par0910" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Recommendation&#58;</span><ul class="elsevierStyleList" id="lis0195"><li class="elsevierStyleListItem" id="lsti0510"><span class="elsevierStyleLabel">&#8226;</span><p id="par0915" class="elsevierStylePara elsevierViewall">Although there is a clear lack of scientific evidence&#44; it seems advisable to wait&#44; if feasible&#44; before placing a new catheter after an episode of CRBSI&#46; The waiting period should be determined by the resolution of signs and symptoms&#46; If a patient urgently needs vascular access&#44; a catheter should be inserted without delay &#40;C-III&#41;&#46;</p></li><li class="elsevierStyleListItem" id="lsti0515"><span class="elsevierStyleLabel">&#8226;</span><p id="par0920" class="elsevierStylePara elsevierViewall">Insertion of a new catheter after a diagnosis of CRBSI is always possible if the patient&#39;s clinical condition dictates the need for a new vascular access &#40;A-III&#41;&#46;</p></li></ul></p></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Conflict of interests</span><p id="par0925" class="elsevierStylePara elsevierViewall">Jaime Esteban has participated in counseling and lectures at meetings sponsored by Laboratorios Leti SL in the last year&#44; as well as received grants for research and teaching from laboratories Pfizer&#44; Sysmex&#44; Angelini and bioM&#233;rieux&#46;</p><p id="par0930" class="elsevierStylePara elsevierViewall">Paula Ramirez has participated in counseling and lectures at meetings sponsored by Pfizer&#44; MSD&#44; Astellas&#44; Gilead and Otsuka in the last year&#44; as well as received grants for research and teaching at Otsuka laboratories&#46;</p><p id="par0935" class="elsevierStylePara elsevierViewall">Jose Luis del Pozo has lectured at meetings sponsored by Pfizer&#44; MSD and Angelini Laboratories&#46;</p><p id="par0940" class="elsevierStylePara elsevierViewall">Miguel Salavert has participated in counseling and lectures at meetings sponsored by MSD&#44; Pfizer&#44; Gilead&#44; Astellas Ph and Angelini in the last year&#44; as well as received grants for research and teaching from Janssen and ViiV laboratories&#46;</p><p id="par0945" class="elsevierStylePara elsevierViewall">Jos&#233; Ram&#243;n Pa&#241;o has participated in counseling and lectures at meetings sponsored by Janssen&#44; Gilead and MSD in the last year&#46;</p><p id="par0950" class="elsevierStylePara elsevierViewall">Jos&#233; Garnacho-Montero has participated in conferences sponsored by MSD and Astellas&#46;</p><p id="par0955" class="elsevierStylePara elsevierViewall">Emilio Bouza has participated in advisory services and lectures sponsored by MSD&#44; Pfizer and Astellas in the last year&#46;</p><p id="par0960" class="elsevierStylePara elsevierViewall">The rest of the authors declare that they have no conflicts of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres975357"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec945180"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres975358"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec945181"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction&#58; justification and aims"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Methods"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "General aspects"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Diagnosis without catheter withdrawal &#40;conservative diagnosis&#41;"
            ]
            2 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "Diagnosis of CRBI with catheter withdrawal"
            ]
            3 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "Diagnosis of local signs of infection"
            ]
          ]
        ]
        6 => array:3 [
          "identificador" => "sec0035"
          "titulo" => "Catheter related bloodstream infection treatment"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "sec0040"
              "titulo" => "Empirical antimicrobial therapy"
            ]
            1 => array:2 [
              "identificador" => "sec0045"
              "titulo" => "Targeted antimicrobial therapy"
            ]
            2 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Conservative treatment&#58; antibiotic lock therapy &#40;ALT&#41;"
            ]
            3 => array:2 [
              "identificador" => "sec0055"
              "titulo" => "Management of local complications"
            ]
            4 => array:2 [
              "identificador" => "sec0060"
              "titulo" => "Patient follow-up"
            ]
          ]
        ]
        7 => array:2 [
          "identificador" => "sec0065"
          "titulo" => "Conflict of interests"
        ]
        8 => array:2 [
          "identificador" => "xack330739"
          "titulo" => "Acknowledgments"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec945180"
          "palabras" => array:5 [
            0 => "Catheter-related bloodstream infection"
            1 => "Guidelines"
            2 => "Bacteremia"
            3 => "Blood cultures"
            4 => "Antibiotic"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec945181"
          "palabras" => array:5 [
            0 => "Bacteriemia relacionada con cat&#233;ter"
            1 => "Gu&#237;a de pr&#225;ctica cl&#237;nica"
            2 => "Bacteriemia"
            3 => "Hemocultivos"
            4 => "Antibioterapia"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Catheter-related bloodstream infections &#40;CRBSI&#41; constitute an important cause of hospital-acquired infection associated with morbidity&#44; mortality&#44; and cost&#46; The aim of these guidelines is to provide updated recommendations for the diagnosis and management of CRBSI in adults&#46; Prevention of CRBSI is excluded&#46; Experts in the field were designated by the two participating Societies &#40;Sociedad Espa&#241;ola de Enfermedades Infecciosas y Microbiolog&#237;a Cl&#237;nica and the Sociedad Espa&#241;ola de Medicina Intensiva&#44; Cr&#237;tica y Unidades Coronarias&#41;&#46; Short-term peripheral venous catheters&#44; non-tunneled and long-term central venous catheters&#44; tunneled catheters and hemodialysis catheters are covered by these guidelines&#46; The panel identified 39 key topics that were formulated in accordance with the PICO format&#46; The strength of the recommendations and quality of the evidence were graded in accordance with ESCMID guidelines&#46; Recommendations are made for the diagnosis of CRBSI with and without catheter removal and of tunnel infection&#46; The document establishes the clinical situations in which a conservative diagnosis of CRBSI &#40;diagnosis without catheter removal&#41; is feasible&#46; Recommendations are also made regarding empirical therapy&#44; pathogen-specific treatment &#40;coagulase-negative staphylococci&#44; <span class="elsevierStyleItalic">Sthaphylococcus aureus</span>&#44; <span class="elsevierStyleItalic">Enterococcus</span> spp&#44; Gram-negative bacilli&#44; and <span class="elsevierStyleItalic">Candida</span> spp&#41;&#44; antibiotic lock therapy&#44; diagnosis and management of suppurative thrombophlebitis and local complications&#46;</p></span>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">La bacteriemia relacionada con cat&#233;teres &#40;BRC&#41; constituye una causa importante de infecci&#243;n hospitalaria y se asocia con elevada morbilidad&#44; mortalidad y costo&#46; El objetivo de esta gu&#237;a de pr&#225;ctica cl&#237;nica es proporcionar recomendaciones actualizadas para el diagn&#243;stico y el tratamiento de la BRC en pacientes adultos&#46; De este documento se excluye la prevenci&#243;n de la BRC&#46; Expertos en la materia fueron designados por las 2 sociedades participantes &#40;Sociedad Espa&#241;ola de Enfermedades Infecciosas y Microbiolog&#237;a Cl&#237;nica y Sociedad Espa&#241;ola de Medicina Intensiva&#44; Cr&#237;tica y Unidades Coronarias&#41;&#46; Los cat&#233;teres venosos perif&#233;ricos a corto plazo&#44; los cat&#233;teres venosos centrales no tunelizados y de largo plazo&#44; los cat&#233;teres tunelizados y los cat&#233;teres de hemodi&#225;lisis est&#225;n incluidos por estas gu&#237;as&#46; El panel identific&#243; 39 temas claves que fueron formulados de acuerdo con el formato PICO&#46; La fuerza de las recomendaciones y la calidad de la evidencia se clasificaron de acuerdo con las directrices de la ESCMID&#46; Se hacen recomendaciones para el diagn&#243;stico de BRC con y sin extracci&#243;n de cat&#233;ter y de la infecci&#243;n en t&#250;nel&#46; El documento establece las situaciones cl&#237;nicas en las que es factible un diagn&#243;stico conservador de CRBSI &#40;diagn&#243;stico sin retirada de cat&#233;ter&#41;&#46; Tambi&#233;n se hacen recomendaciones con respecto a la terapia emp&#237;rica&#44; el tratamiento espec&#237;fico seg&#250;n el pat&#243;geno identificado &#40;estafilococos coagulasa negativos&#44; <span class="elsevierStyleItalic">Staphylococcus aureus</span>&#44; <span class="elsevierStyleItalic">Enterococcus</span> spp&#44; bacilos gramnegativos y <span class="elsevierStyleItalic">Candida</span> spp&#41;&#44; la terapia con sellado del cat&#233;ter&#44; el diagn&#243;stico&#44; as&#237; como el tratamiento de la tromboflebitis supurativa y las complicaciones locales&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:2 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">The consensus statement is available at&#58; <span class="elsevierStyleInterRef" id="intr0005" href="https://www.seimc.org/contenidos/documentoscientificos/guiasclinicas/seimc-guiasclinicas-2017-Catheter-Related_Bloodstream_Infection.pdf">https&#58;&#47;&#47;www&#46;seimc&#46;org&#47;contenidos&#47;documentoscientificos&#47;guiasclinicas&#47;seimc-guiasclinicas-2017-Catheter-Related&#95;Bloodstream&#95;Infection&#46;pdf</span> and as additional material in the journal official website&#46;</p>"
      ]
      1 => array:2 [
        "etiqueta" => "&#9734;&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0010">The complete consensus statement has also been published in&#58; Medicina Intensiva&#46; 2017&#46; <span class="elsevierStyleInterRef" id="intr0010" href="http://dx.doi.org/10.1016/10.1016/j.medin.2017.09.012">http&#58;&#47;&#47;dx&#46;doi&#46;org&#47;10&#46;1016&#47;10&#46;1016&#47;j&#46;medin&#46;2017&#46;09&#46;012</span></p>"
      ]
    ]
    "apendice" => array:1 [
      0 => array:1 [
        "seccion" => array:1 [
          0 => array:4 [
            "apendice" => "<p id="par1055" class="elsevierStylePara elsevierViewall">The following are the supplementary data to this article&#58;<elsevierMultimedia ident="upi0005"></elsevierMultimedia></p>"
            "etiqueta" => "Appendix B"
            "titulo" => "Supplementary data"
            "identificador" => "sec0080"
          ]
        ]
      ]
    ]
    "multimedia" => array:2 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Category&#47;grading strength of recommendations&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Definition&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">A</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Strongly supports a recommendation for use&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">B</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Moderately supports a recommendation for use&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">C</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Marginally supports a recommendation for use&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">D</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Supports a recommendation against use&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Quality of evidence</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>I&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Evidence from at least one properly designed randomized&#44; controlled trial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>II&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Evidence from at least one well-designed clinical trial&#44; without randomization&#59; from cohort or case-controlled analytic studies &#40;preferably from 1 center&#41;&#59; from multiple time series&#59; or from dramatic results of uncontrolled experiments&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>III&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Evidence from opinions of respected authorities&#44; based on clinical experience&#44; descriptive case studies&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1651635.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Strength of recommendation and quality of evidence&#46;</p>"
        ]
      ]
      1 => array:5 [
        "identificador" => "upi0005"
        "tipo" => "MULTIMEDIAECOMPONENTE"
        "mostrarFloat" => false
        "mostrarDisplay" => true
        "Ecomponente" => array:2 [
          "fichero" => "mmc1.pdf"
          "ficheroTamanyo" => 548250
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:7 [
            0 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "EPINE 2015&#46; INFORME GLOBAL DE ESPA&#209;A&#46; RESUMEN &#8211; EPINE 2015 INFORME GLOBAL DE ESPA&#209;A RESUMEN&#46;pdf &#91;Internet&#93;&#46; Available from&#58; <a href="http://hws.vhebron.net/epine/Descargas/EPINE%202015%20INFORME%20GLOBAL%20DE%20ESPA%C3%91A%20RESUMEN.pdf">http&#58;&#47;&#47;hws&#46;vhebron&#46;net&#47;epine&#47;Descargas&#47;EPINE&#37;202015&#37;20INFORME&#37;20GLOBAL&#37;20DE&#37;20ESPA&#37;C3&#37;91A&#37;20RESUMEN&#46;pdf</a> &#91;accessed 19&#46;11&#46;16&#93;&#46;"
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "&#91;Infections related to intravascular devices used for infusion therapy&#93;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "J&#46; Fort&#250;n"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Enferm Infecc Microbiol Clin"
                        "fecha" => "2008"
                        "volumen" => "26"
                        "paginaInicial" => "168"
                        "paginaFinal" => "174"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18358216"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Epidemiology and clinical features of community-acquired&#44; healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Rodr&#237;guez-Ba&#241;o"
                            1 => "M&#46;D&#46; L&#243;pez-Prieto"
                            2 => "M&#46;M&#46; Portillo"
                            3 => "P&#46; Retamar"
                            4 => "C&#46; Natera"
                            5 => "E&#46; Nu&#241;o"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1469-0691.2009.03089.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Microbiol Infect"
                        "fecha" => "2010"
                        "volumen" => "16"
                        "paginaInicial" => "1408"
                        "paginaFinal" => "1413"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19845694"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "&#91;Costs associated with nosocomial bacteraemias in a University Hospital&#93;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Riu"
                            1 => "R&#46; Terradas"
                            2 => "M&#46; Sala"
                            3 => "M&#46; Comas"
                            4 => "H&#46; Knobel"
                            5 => "S&#46; Grau"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.eimc.2011.11.006"
                      "Revista" => array:6 [
                        "tituloSerie" => "Enferm Infecc Microbiol Clin"
                        "fecha" => "2012"
                        "volumen" => "30"
                        "paginaInicial" => "137"
                        "paginaFinal" => "142"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22206947"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Morbidity and mortality associated with primary and catheter-related bloodstream infections in critically ill patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46;M&#46; Olaechea"
                            1 => "M&#46; Palomar"
                            2 => "F&#46; &#193;lvarez-Lerma"
                            3 => "J&#46;J&#46; Otal"
                            4 => "J&#46; Insausti"
                            5 => "M&#46;J&#46; L&#243;pez-Pueyo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Esp Quimioter"
                        "fecha" => "2013"
                        "volumen" => "26"
                        "paginaInicial" => "21"
                        "paginaFinal" => "29"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23546458"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intravascular catheter-related infections&#58; advances in diagnosis&#44; prevention&#44; and management"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "I&#46; Raad"
                            1 => "H&#46; Hanna"
                            2 => "D&#46; Maki"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S1473-3099(07)70235-9"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet Infect Dis"
                        "fecha" => "2007"
                        "volumen" => "7"
                        "paginaInicial" => "645"
                        "paginaFinal" => "657"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17897607"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "&#91;Guidelines for the treatment of short-term intravascular catheter-related infections in adults&#59; SEIMC-SEMICYUC Consensus Conference&#93;"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "SEIMC&#44; SEMICYUC"
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Le&#243;n"
                            1 => "J&#46; Ariza"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Enferm Infecc Microbiol Clin"
                        "fecha" => "2004"
                        "volumen" => "22"
                        "paginaInicial" => "92"
                        "paginaFinal" => "101"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14756991"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "agradecimientos" => array:1 [
      0 => array:4 [
        "identificador" => "xack330739"
        "titulo" => "Acknowledgments"
        "texto" => "<p id="par0965" class="elsevierStylePara elsevierViewall">The authors thank Dr&#46; Antonio Guti&#233;rrez-Pizarraya for his commentaries and technical support for the elaboration of this document&#46;</p>"
        "vista" => "all"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/0213005X/0000003600000002/v2_201802071725/S0213005X17303130/v2_201802071725/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "8681"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Documento de consenso"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/0213005X/0000003600000002/v2_201802071725/S0213005X17303130/v2_201802071725/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X17303130?idApp=UINPBA00004N"
]

Article information

ISSN: 0213005X
Original language: English

DOI:10.1016/j.eimc.2017.10.019

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	15	10	25
2024 October	163	48	211
2024 September	161	69	230
2024 August	115	75	190
2024 July	118	79	197
2024 June	77	57	134
2024 May	94	87	181
2024 April	97	73	170
2024 March	120	75	195
2024 February	138	90	228
2024 January	131	120	251
2023 December	119	115	234
2023 November	137	141	278
2023 October	134	132	266
2023 September	202	130	332
2023 August	87	102	189
2023 July	164	81	245
2023 June	152	69	221
2023 May	158	93	251
2023 April	112	42	154
2023 March	152	54	206
2023 February	90	24	114
2023 January	91	17	108
2022 December	77	31	108
2022 November	103	34	137
2022 October	73	52	125
2022 September	94	46	140
2022 August	70	46	116
2022 July	100	39	139
2022 June	67	20	87
2022 May	97	35	132
2022 April	131	36	167
2022 March	81	24	105
2022 February	60	23	83
2022 January	79	32	111
2021 December	92	41	133
2021 November	91	40	131
2021 October	79	44	123
2021 September	66	24	90
2021 August	130	45	175
2021 July	98	25	123
2021 June	76	30	106
2021 May	107	34	141
2021 April	546	67	613
2021 March	287	63	350
2021 February	135	41	176
2021 January	152	38	190
2020 December	119	27	146
2020 November	101	29	130
2020 October	88	27	115
2020 September	89	18	107
2020 August	102	24	126
2020 July	105	14	119
2020 June	93	23	116
2020 May	96	42	138
2020 April	80	18	98
2020 March	82	17	99
2020 February	94	32	126
2020 January	85	28	113
2019 December	95	28	123
2019 November	67	28	95
2019 October	91	47	138
2019 September	98	24	122
2019 August	82	20	102
2019 July	84	37	121
2019 June	131	37	168
2019 May	315	39	354
2019 April	113	51	164
2019 March	69	30	99
2019 February	63	21	84
2019 January	76	32	108
2018 December	59	19	78
2018 November	67	37	104
2018 October	86	32	118
2018 September	49	13	62
2018 August	44	1	45
2018 July	9	1	10
2018 June	7	0	7
2018 May	6	0	6
2018 April	9	7	16
2018 March	31	20	51
2018 February	156	192	348

Show all

Indexed in:

Follow us:

Subscribe:

Statistics

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter